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ABSTRACT
Galactooligosaccharides (GOS) are prebiotics that have a beneficial effect on human
health by promoting the growth of probiotic bacteria in the gut. GOS are commonly
produced from lactose in a reaction catalysed by β-galactosidase, termed
transglycosylation.
In the present work the synthesis of GOS from Whey Permeate (WP) using
commercially available β-galactosidases was studied. The enzymes used were from
Kluyveromyces lactis (Maxilact® L2000) and Escherichia coli.
Initially, a novel quantitative TLC-based assay to monitor GOS synthesis was
developed. This method was employed for kinetic analysis but precision and bias
problems in quantification were observed. An HPLC assay was subsequently
developed and used to quantitate the kinetics of GOS synthesis.
The influence of substrate concentrations of WP and enzyme concentrations were
examined. The reaction kinetics showed an exponential consumption of lactose, while
the GOS reached a maximum level and decreased thereafter. The data showed that the
enzyme and WP concentrations influenced the maximum level of GOS synthesis. The
maximum yield of GOS from WP was found to be 24%.
Modelling of GOS synthesis profiles using a full reaction mechanism (Kim et al.,
2004) fitted the experimental data. However, high correlation between kinetic
parameters and high standard errors in parameter estimates were found. Therefore, a
simplified GOS synthesis mechanism based on simplifying assumptions previously
identified in literature was devised. This reduced model fitted data appropriately and
parameter estimation and associated uncertainty was improved.
The influence of low amounts of organic solvents on GOS synthesis was examined.
The progress curve in the presence of solvents was probed using the reduced reaction
mechanism model.
To examine the influence of the source of enzyme on GOS synthesis, two βgalactosidases were compared. Data showed that when reaction conditions were
identical there was no significant difference in GOS synthesis observed.
These studies show Whey Permeate is a useful material for GOS synthesis. They
confirm the literature observations that enzyme and substrate concentrations strongly
influence GOS yields. The use of organic solvents was found to modify the reaction
kinetics, with promising applications to increase GOS yield. However, the source of
enzyme may not influence GOS synthesis to the extent believed in the literature.
Keywords: Galactooligosaccharides, β-galactosidase, Whey Permeate.
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1 Introduction
1.1 General
The dairy industry is one of the oldest and most developed industries in the
world. In particular, the European dairy industry is transforming 130 billion litres of
raw milk every year into a broad range of products, both for consumption and for
application in the production of food, feed and pharmaceutical products (Hilliam,
1990).
The dairy industry produces a large quantity of by-products, which requires
that particular attention is paid to their disposal due to the dissolved sugars, proteins,
fats, and residues of additives, contained in the effluents. According to the World
Bank Group (1996), in the untreated effluents of the dairy industry, the biochemical
oxygen demand (BOD) has an average value ranging from 0.8-2.5 kg/t. The effluent
chemical oxygen demand (COD) is normally about 1.5 times the BOD level and the
total suspended solids are about 100 to 1,000 mg/l, of which phosphorus comprises 10
to 100 mg/l and nitrogen 6% of BOD level.
The major source of BOD in wastewater of dairy industries derives from the
production processes for butter, cream, and cheese. The latter gives rise to whey as a
by-product. Annual global milk production in 2007 is estimated of over 534
thousands of metric tons, whose transformation to cheese gave up to two thousand of
metric tons of whey (Commodity Research of Bureau, 2007). Whey accounts for
most of the BOD, between 38,000-40,000 ppm (Bullerman et al., 1966), and
dissolved salts of dairy industries wastewater. Considering the 3% annual increase in
cheese production (Foda et al., 2000) whey surplus is a major and increasing concern
for the dairy industry.
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However, most of the solid waste of the dairy industry can be further utilized
or processed. A common use for surplus whey is its addition to animal feed,
especially in America, with 90% of American production used (Wastendorf, 2000).
Whey has been also been used as a fertilizer, because it improves soil texture and
contains nutrients, such as nitrogen, phosphorus, and potassium in the proper
proportions (Yang et al., 1995). Whey needs to be treated before it can be used as
fertilizer. In the past many industries discharged whey into lakes and rivers to remove
the economic burden of disposing of whey in waste treatment facilities. In recent
years, the Environmental Protection Agency (EPA) has placed restrictions on landspreading as a method for whey disposal. This serves has served as an important
incentive to find other uses for whey (Casper et al., 1999). In some European
countries, such as Italy, France, Greek and Spain, whey almost entirely used for the
production of a typical soft unreaped cheese, called ricotta, with a production of over
450 tons (Fox, 1999).

1.1.2 Whey: definition, components and their use
Whey is defined as the greenish-yellow coloured liquid obtained after the
coagulation of casein (Stocking, 2008). It is produced from the process that leads to
curds formation during the cheese making process (Smithers et al., 1996) (Figure 1.0).

Figure 1.0: Curds and whey. Milk proteins are precipitated leaving a yellowish
liquid (whey).
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Whey contains nearly half of all the solids found in whole milk (Chandan,
1997). It has about 6.5% solids, of which 4.8% is lactose, 0.6% protein, 0.15% lactic
acid, 0.25% non-protein nitrogen compounds and 0.1% fat (Ranken et al., 1997).
Lactose is a disaccharide composed of β-D-Galactopyranosyl and β-DGlucopyranose linked with a β-1→4 bond.
Whey proteins consist predominantly of β-lactoglobulin, α-lactalbumin,
immunoglobulins and serum albumin. However, whey also contains minerals
(calcium, magnesium, phosphate, citrate, sodium, potassium and chloride),
antibacterial peptides (lactoferrin and lactoperoxidase), and vitamins (B1, B2, and C)
(Wong et al., 1978).
Depending on how casein is coagulated (acid or enzymatic coagulation), whey
can be classified as sweet (pH 6.4-6.2) with no calcium, or acid (pH 5.0-4.6), which
contains a high amount of calcium 92.8 mg/100g (Wong et al., 1978; Yang, 2007).
Whey, freshly prepared, has a bland flavour (Laye et al., 1993), which allows
it to blend well with most products. However, it rapidly oxidizes, giving rise to stale
off-flavours (Morr et al., 1991). For this reason, together with economic aspects of
transport and storage, whey components are generally separated, through filtration
techniques such as reverse osmosis or ultrafiltration, and transformed into a dry
product, through evaporation techniques, such as spray-drying. According to Tamime,
(2009), Whey powders are manufactured as three main products:
-

Whey protein concentrate (WPC), which contains 70-85% of the whey
proteins of milk and 50% of the lactose of milk.

-

Whey protein isolate (WPI), which contains more protein (90-98%)
than WPC and very little fat or lactose.
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-

Whey Permeate (WP), which contains essentially lactose and some
minerals and minimal fat and protein.

Whey proteins are commonly used in formulation of infant foods, integrators,
bakery products, and meat products.
Currently, whey permeate is mainly used in the manufacturing of dried whey
powder for the production of refined lactose. The application of whey described
above, however, are often aimed at keeping the surplus whey out of sewers rather
producing highly desirable products (Yang, 2007). It is therefore, of interest to
investigate novel uses of whey permeate.

1.1.3 Oligosaccharides: definition, production, classification
Oligosaccharides, usually defined as glycosides of different degrees of
polymerization (DP), may be synthesised both by enzymatic and chemical means.
Examples of oligosaccharides are: lactulose, raffinose, maltooligosaccharides, inulin,
fructooligosaccharides (FOS) and galactooligosaccharides (GOS). Lactulose has a
mildly purgative action and inhibits the growth of ammonia-producing organisms
(Harju, 1993). Lactulose is currently used as a pharmaceutical for the control of
constipation and portosystemic encephalophathy (Crittenden et al., 1996).
Maltooligosaccharides improve colonic conditions by reducing the level of
Enterobacteriacea in the gut (Nakakuki, 1993). Inulin and FOS are non-cariogenic,
encourage the growth of beneficial bifidobacteria, and decrease the levels of serum
cholesterol, phospholipids, and triglycerides (Hidaka et al., 1986). Raffinose ingestion
increases the number of bifidobacteria (Taizo et al., 1999).
Chemical synthesis of oligosaccharides can be carried out through the use of
glycosylating agents, such as glycosyl sulfoxides, glycosyl halides and thioglycosides
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(Bartolozzi et al., 2001). However, the product mixtures obtained are often quite
complex and ill defined. Selective synthesis of oligosaccharides requires many
reaction steps with the use of protection/deprotection of hydroxyl groups, resulting in
low yields of final products, and often, the formation of unwanted enantiomers
(Flowers, 1978).
In contrast to chemical synthesis, enzymatic synthesis of oligosaccharides
generally produces few by-products, avoids the need for protection/deprotection
chemistry, and is environmentally of low impact. For these reasons this procedure is
most commonly used. Thus, transglycosylation of lactose by β-galactosidase is widely
used to synthesise GOS. Fructanotransferase catalyses the synthesis of FOS from
sucrose. Lactosucrose can be synthesised from sucrose through the activity of
levansucrase. Transglycosylation of soluble starch by glycosyl hydrolases is used to
synthesise glycosylsucrose. Xylo- and chitin- oligosaccharides may be obtained by
enzymatic hydrolysis of oligosaccharides using β-xylanase and chitinase respectively.
Some oligosaccharides, such as inulin and soybean (raffinose and stachyose), can be
extracted

from

natural

sources

(Sako

et

al.,

1999)

(Figure

1.1).
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Figure 1.1: Schematic representation of production processes for non-digestible
oligosaccharides (NDOs) (from Sako et al., 1999).

Non digestible oligosaccharides (NDOs) are useful as prebiotics. In the
gastrointestinal tract they serve as substrates for probiotic or “beneficial” bacteria.
The most common NDOs used as food ingredients are fructooligosaccharides and
galactooligosaccharides. FOS and GOS are generally produced by enzymatic
transglycosylation by fructanotransferase and β-galactosidase respectively. The
industrial process for enzymatic galactooligosaccharides synthesis is shown in Figure
1.2.
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Figure 1.2: Industrial production process for GOS. The figure also shows two
possible types of GOS products: Gal-β-1→4-Gal-β-1→4-Glc (4’-galactosyllactose)
and Gal-β-1→6-Gal-β-1→4-Glc (6’-galactosyllactose), where Gal: Galactose, Glc:
Glucose (from Matsumoto et al., 1990).
1.1.3.1 Galactooligosaccharides: definition, functionality and structure
Galactooligosaccharides have a generic formula of D-Glucose-[β-DGalactose]n where n ranges between three and ten sugar moieties. GOS may be
regarded as non digestible oligosaccharides or soluble dietary fibres because they are
not digestible by the enzymes of the small intestine, but they are fermentable by
bacteria in the large intestine (Champ et al., 2003). This is due to the substrate
specificity of human gastrointestinal digestive enzymes, which are mostly specific for
α-glycosidic bonds whereas GOS glycosidic bonds have a β-configuration. Some βgalactosidases, localized in the small intestine, are able to digest GOS but their
activity is usually weak or often deficient (Ito et al., 1993).
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Oral GOS assumption beneficially affects the human body by selectively
stimulating the growth and/or activity of one or a limited number of bacteria in the
colon. In this way galactooligosaccharides cause a selective modification of the
intestinal microflora, associated with a decrease in faecal pH (Hidaka et al., 1988).
Such bacteria are able to create an acid medium unfavourable to the growth of many
pathogenic microorganisms (Kunz et al., 1993). The end products of fermentation of
oligosaccharides by colonic bacteria are short chain fatty acids (SCFA) such as acetic,
propionic and lactic acid (Hidaka et al., 1986; Hidaka et al., 1988), which are thought
to be efficiently absorbed and utilized by human colonic epithelial cells. In particular,
acetic and lactic acids are able to inhibit the growth of undesirable bacteria such as
Esherichia coli and Clostridium perfingens (Tanaka et al., 1983).
The carbohydrate composition of food is thought to be an important
determinant of the composition of the intestinal flora (Sako et al., 1999). The
introduction of GOS into foods is considered desirable (Matsumoto et al., 1989;
Huffman et al., 1985; Chen et al., 1991).
A large number of GOS species may be synthesized using an enzymatic
transglycosylation reaction with lactose as substrate (Tanaka et al., 1983; Smart,
1993).
Investigations of GOS synthesis using Aspergillus oryzae (Toba et al., 1978)
and Streptococcus thermophilus (Matsumoto, 1990) β-galactosidases have identified
disaccharides containing galactose linked to glucose with various types of glycosidic
bonds, such as β-1→2, β-1→3, β-1→4, and to galactose through bonds β-1→6 and β1→3. Glycosidic bonds between two galactose units are mainly β-1→4 bonds when
β-galactosidases derived from Bacillus circulans (Mozaffar et al., 1984) and
Cryptococcus laurentii (Ozawa et al., 1989) are used. The disaccharides synthesized
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by β-galactosidase are also called transgalactosylated disaccharides (TD), since the
bonds between the monosaccharide moieties are different from those present in
nature. TDs may be considered as non digestible oligosaccharides (NDOs), since they
have similar physiological characteristics to GOS. Transgalactosylated disaccharides,
together with lactose, serve as acceptors for the synthesis of tri- and highersaccharides. It would seem that galactose can be transferred to any of the hydroxyl
groups on acceptor sugars, except for the C1 hydroxyl (Mahoney, 1998).
The length of the chain of galactooligosaccharides generated by enzymatic
reaction depends on the lactose concentration in the media (Huh, 1990; Lopez-Leiva
et al., 1995; Rustom et al., 1998). Quantitatively, the amount of the different GOS
products present appears to follow the order: di- > tri- > tetra- > higher- saccharides
and the linkages synthesized are predominantly β-(1→6) > β-(1→3) and β-(1→2)
(Prenosil et al., 1987; Toba et al., 1978; Smart, 1993). Trisaccharides, especially
galactosyl 1→6 lactose, can be identified at most lactose levels. Tetra- and highersaccharides have been reported only when using much higher starting lactose levels,
although they are considered to be formed at most lactose concentrations but in
quantities too small to be detected (Mahoney, 1998). Commercially, short chain
oligosaccharides are preferable to long-chain oligosaccharides as human food
additives because they are more easily metabolized by the human gut bifidobacteria
(Mul, 1997) and also because short-chain oligosaccharides, after metabolism in the
human body, are more efficient in the production of short-chain fatty acids (SCFA)
(Mul, 1997; Knudsen, 1997).
A list of oligosaccharide structures identified in GOS preparations is given in
Table 1.0.
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Table 1.0: List of oligosaccharide structures identified in GOS preparations. Where
Gal: Galactose, Glc: Glucose. (Adapted from Mahoney et al., 1998).
GOS component
Disaccharides

Trisaccharides

Tetrasaccharides

Pentasaccharides

Chemical structure
β-D-Gal (1→6)-D-Glc
β-D-Gal (1→6)-D-Gal
β-D-Gal (1→3)-D-Glc
β-D-Gal (1→2)-D-Glc
β-D-Gal (1→3)-D-Gal
β-D-Gal (1→6)-β-D-Gal (1→6)-D-Glc
β-D-Gal (1→6)-β-D-Gal (1→4)-D-Glc
β-D-Gal (1→6)-β-D-Gal (1→6)-D-Gal
β-D-Gal (1→3)-β-D-Gal (1→4)-D-Glc
β-D-Gal (1→4)-β-D-Gal (1→4)-D-Glc
β-D-Gal (1→6)-β-D-Gal (1→6)-β-D-Gal (1→4)-D-Glc
β-D-Gal (1→6)-β-D-Gal (1→3)-β-D-Gal (1→4)-D-Glc
β-D-Gal (1→3)-β-D-Gal (1→6)-β-D-Gal (1→4)-D-Glc
β-D-Gal (1→6)-β-D-Gal (1→6)-β-D-Gal (1→6)-β-D-Gal(1→4)-D-Glc

1.1.4 β-galactosidase: reaction mechanism, products, applications
β-galactosidase (β-gal) (EC 3.2.1.23) is a galactosyl hydrolase which cleaves
lactose, releasing glucose and galactose. This enzyme was one of the first enzymes
isolated and purified from various natural sources, such as plants, animal organs and
microorganisms (Richmond et al., 1981) (Table 1.1).

Table 1.1: Sources of β-galactosidase (Adapted from Richmond et al., 1981).
Plants

Animal organs

Yeast

Peach
Apricot
Almond
Kefir grains
Tips of wild roses
Alfalfa seeds
Coffee beans

Intestine
Brain
Skin tissue
Bovine liver

Kluyveromyces lactis
Kluyveromyces fragilis
Candida pseudotropicalis

Bacteria
Escherichia coli
Bacillus megaterium
Thermus acquaticus
Streptococcus lactis
S. thermophilus
L.. bulgaricus
L. helareticus

Fungi
Neurospora crassa
Aspergillus foetidus
Aspergillus niger
Aspergillus flavus
Aspergillus oryzae
A. phoenicis
Mucor pucillus
Mucor meuhei

The functional form of E. coli β-galactosidase is a tetramer of four identical
subunits (Appel et al., 1965), each consisting of 1,023 amino acid residues (Fowler et
al., 1970). The tetramer, of 465.412 Da, has a 222-point of symmetry (Jacobson et al.,
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1994) and consists of five domains, the third of which has the active site (Matthews et
al., 2005) (Figure 1.3).

Figure 1.3: 3-D structure of the tetrameric E coli β-galactosidase. The colours
indicate the four different E. coli identical subunits (From Miesfeld, 2001).

β-galactosidase catalyses the transfer of a galactose moiety of a β-galactoside
to an acceptor containing a hydroxyl group.
The reaction mechanism for β-galactosidase has been elucidated and proceeds
by two steps (Figure 1.4):
-

Step (a): enzyme–galactosyl complex formation and simultaneous
glucose liberation.

-

Step (b): the enzyme–galactosyl complex is transferred to
nucleophilic acceptor containing a hydroxyl group. Transfer to water
produces galactose (hydrolysis reaction, Figure 1.4 b, where -R is a
hydrogen). Transfer to another sugar produces di-, tri- and higher
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galactosyl-saccharides, collectively termed galactooligosaccharides
(Figure 1.4 b, where -R is a sugar molecule).

(a)

(b)

Figure 1.4: Reaction mechanism for the hydrolysis and transglycosylation of
lactose by Kluyveromyces lactis β-galactosidase. (a): The lactose molecule on the
active site of the enzyme forms and acyl-enzyme complex with liberation of glucose.
(b): The enzyme-galactose complex, formed by lactose hydrolysis, could react with
carbohydrate molecules (where R: mono- or di- saccharides), leading to GOS
formation. Glutamate 551 act as the nucleophile and glutamate 482 is the proton
donor. (Adapted from Zhou et al., 2001).

In 1957, Roberts et al. showed that transglycosylation by β-galactosidase from
Saccharomyces fragilis was useful for the synthesis of GOS from lactose. Thus, a
reaction mixture of 15% of lactose with 0.5% Saccharomyces fragilis β-galactosidase
leads to formation of GOS from lactose as follows (Figure1.5).
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Figure 1.5: GOS synthesis from lactose by Saccharomyces fragilis βgalactosidase. Reactions were carried out in phosphate buffer (0.067M, pH 6.2) and
35ºC (Roberts et al., 1957).

Therefore, in aqueous solutions with high concentrations of competing
hydroxyl groups on sugar moieties, the enzyme catalyses the formation of
galactooligosaccharides (GOS) (Huh, 1990; Lopez-Leiva et al., 1995; Rustom et al.,
1998). The ratio of products results from competition between water and the
carbohydrate acceptor for enzyme bound substrate (Figure 1.6).
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Figure 1.6: Reaction pathway for transglycosylation and hydrolysis βgalactosidase. Lactose hydrolysis (lower path) and transgalactosylation reaction
(upper path) are both catalysed by β-galactosidase, depending on the sugar
concentration in solution (Neri, 2008).

Therefore, the β-galactosidase reaction mechanism includes both the
hydrolysis of lactose and a transglycosylation reaction (Mahoney, 1998). Depending
on lactose concentration, the reaction is shifted towards either hydrolysis or
transglycosylation. When water concentration in the system, expressed as water
activity (aw), is high, the hydrolysis of lactose occurs predominantly. The
transglycosylation reaction increases with a decrease in water activity (Goulas et al.,
2007). Apart from lactose concentration, other factors influence the reaction, such as:
reaction conditions temperature, pH and the presence of inhibitors or activators
specific for the enzyme (Zárate et al., 1990).
The β-galactosidase reaction mechanism involves two critical amino acid
residues on the protein, a proton donor and a nucleophile/base. The mechanism of the
reaction, first described by Wallenfels et al., (1960), proposed that cysteine and
histidine residues acted as proton donor and nucleophile site respectively. This was
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subsequently confirmed (Nizizawa et al., 1970; Nijipels et al., 1981; Prenosil et al.,
1987). However, recent studies (Huh, 1990; Sheu et al., 1998; Mahoney et al., 1998;
Zhou et al., 2001) have show that microbial β-galactosidases have two glutamate
residues, one acting as the proton donor and the other as a nucleophile/base (Figure
1.4).
Jobe et al. (1972) showed that allolactose, β-D-Galactopyranosyl (1→6)-DGlucose, is a primary transfer product of the transglycosylation reaction. They
demonstrated the capacity of β-galactosidase to modify the 1→4 linkage to a 1→6
linkage (Figure 1.7). The major pathway for production of this compound is direct
internal transfer of galactose from the 4 position to the 6 position of the glucose
moiety without releasing the glucose from the active site (Huber et al., 1976).

Figure 1.7: Allolactose production from lactose by β-galactosidase. The glycosidic
linkage 1→4 is modified to 1→6 linkage (from Horton et al., 2006).
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Many authors (Bakken et al., 1992; Portaccio et al., 1998; Shukla et al., 1993)
have reported galactose to be a competitive inhibitor of lactose hydrolysis and
transglycosylation reactions. From a thermodynamic point of view, high galactose
concentrations might be expected to favour the transglycosylation reaction, increasing
GOS yield. Nevertheless, Neri et al., (2009) investigating the effects of galactose
and/or glucose addition on transglycosylation, found a simultaneous decrease in
lactose hydrolysis and transglycosylation in the presence of galactose, presumably due
to galactose inhibition (Prenosil et al, 1987; Santos et al., 1998).
Glucose also influences the transglycosylation reaction kinetics acting as a
non-competitive inhibitor (Shin et al., 1998; Cavaille et al., 1995).
According to Peinsipp et al., (1995), during the transglycosylation reaction,
lactose may serve as donor as well an acceptor of a glycosyl group and the isolated
product is β-D-Galactose (1→6)-β-D-Galactose-(1→4)-D-Glucose (Figure 1.8).

2 ·Lactose
Figure

1.8:

β-D-Gal-(1→6)-β-D-Gal-(1→4)-D-Glc

β-D-Galactose-(1→6)-β-D-Galactose-(1→4)-D-Glucose

using β-galactosidase.

synthesis

Lactose is hydrolysed to liberate glucose. The resulting

enzyme-galactosyl complex reacts to form a 1→6 linkage with the galactose moiety
of a second lactose molecule (Peinsipp et al., 1995).
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The efficiency of transglycosylation, the linkage between the units, the
components in the final product and the yield of GOS have been reported to depend
upon the source of the enzyme and the reaction conditions used (Sako et al., 1999;
Boon et al., 2000). Indeed, the degree of oligosaccharide formation has been reported
to be as high as 40% of the total sugar content of the solution under optimal reaction
conditions (Prenosil et al., 1987). However, a difficulty with comparison between
studies lies in the fact that they have been carried out using different enzymes under
widely varying conditions of temperature and pH and substrate concentration without
the use of a comparator.
Transglycosylation is an intermediate step of a more complex reaction
because, as it progresses, all sugars may be hydrolyzed to their constitutive
monosaccharides (Matella et al., 2006). Hence, knowledge of the time course of the
reaction is required to estimate the point of maximum yield for the desired GOS
products.
The process of lactose hydrolysis by β-galactosidase is used industrially
whether the interest in removing lactose from milk products is based on nutritional
considerations (lactose intolerance) or technological concerns (lactose solubility,
sweetness, functionality). Lactose-hydrolyzed milk is used for the preparation of
flavoured milk and fermented products (yoghurt, cheese and bakery products) as it
accelerates acidification due to the release of glucose. It is also used for ice-creams, as
it prevents lactose crystallization; as well as a sugar source in animal feed (Yang et
al., 1995).
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1.2 Functional food
The concept of “functional food” was developed in Japan in the mid 1980s. At
that time, the health authorities in Japan decided that greater consumption of certain
food types could help to limit or reduce the impact of a number of disease risk factors.
After a relatively slow start, the concept of functional foods has stimulated
interest among the major food companies around the world. The functional food
market is estimated to be worth $43 billion in the US, with an annual market growth
rate of 5-10% (Sloan, 1999). A European survey estimated the functional food market
to be worth over about 1€ billion in 1997 (Table 1.2). The global functional food
market increased from 10,000 US $ million in 1995 (Byrne et al., 1997) to 33,000 $
million in the year 2000 (Hilliam, 2000) and is predicted to be over 50,000 in 2010
(Heller, 2001). Dairy products are one of the most developed sector of the European
functional food market.

Table 1.2: Functional dairy products in Europe by country (from Hilliam, 2000).
Country
Germany
France
United Kingdom
The Netherlands
Other countries
Total

Value in 1999
(US $ millions)
283
240
222
150
450
1345

Share
(%)
21
18
16
11
34
100

1.2.1 Definition of functional foods
In 1996, Roberfroid was one of the first to define a functional food as “a
dietary component that may exert physiological effects on the consumer which may
eventually lead towards justifiable health claims”. While a globally accepted
definition has yet to be agreed, a functional food is broadly regarded as any food or
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ingredient that, in addition to providing nutritional benefit, may contribute a health
benefit (Marriott, 2000). Those benefits can be of various types.

According to

Bellisle et al., 1998, a functional food affects one or a limited number of functions in
the body in a targeted way so as to have positive effects on health. Other workers have
defined such foods as having a physiological or psychological benefit (Clydesdale,
1997) and/or reducing the risk of chronic disease beyond their basic nutritional
functions (Hasler, 1998).
For the food industry, functional properties are those attributes of food
components or additives that, at their proper concentration and under suitable
conditions, provide desirable sensory and rheological characteristics (Sikorski, 2001).
Traditionally, fruits and vegetable have been seen as a source of functional
food components, but recent investigations have established that animal food
derivatives, such as milk and dairy products may also be a valuable source of these
components (Bauman et al., 2006).

1.2.2 Concepts and legislation for functional foods
The attribution of health claims to foods led to the development of a wide
variety of foods claiming such benefits. On the one hand, this indicates the extent of
innovation and competitiveness of the food industry, but on the other hand it
highlights the need for regulation to ensure legitimacy and that consumers are not
misled.
In Europe, the European Commission’s concerted action on Functional Food
Science in Europe (FUFOSE), involving a large number of the most prominent
European experts in nutrition and related sciences, were engaged by the International
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Life Science Institute (ILSI) (Diplock et al., 1999) to define the claims criteria for
functional foods.
European Regulation EC No. 1924/2006 harmonises laws, regulations or
administrative actions in Member States which relate to nutrition and health claims of
foods in order to ensure the effective functioning of the market whilst providing a
high level of consumer protection (Official Journal of the European Union, 2007).
In the European Union (EU) the legal status of functional food is regulated
through existing food legislation. However, specific authorisation must be obtained
through the process set out in the Novel Food Regulations prior to placing a new food
on the EU market (EC No. 258/1997). For these reasons in the EU functional foods
are not legally considered as a specific food category, but rather a concept (Coppens
et al., 2006; Stanton et al., 2005).
In the EU some of the functional foods already available are those with
cholesterol lowering plant sterols and stanols, as well as those containing live bacteria
(probiotics) that enhance the quality of human gut microflora. During the manufacture
of functional fermented milks, oligosaccharides are produced in variable amounts
depending on the bacterial strains used (Joung et al., 2001; Lamoureux et al., 2002;
Yadav et al., 2007), so the functional properties of fermented milks may be due not
only to their probiotic properties but also to the presence of oligosaccharides
(Martínez-Villaluenga et al., 2008).
Functional food research has moved progressively towards the development of
dietary supplementation, introducing the concept of prebiotics, which may affect gut
microbial composition (Ziemer et al., 1998).
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1.3 Oligosaccharides industrial properties or applications and prebiotics
properties
In 1991, the Ministry of Health and Welfare in Japan legislated as foods for
specified health use (FOSHU): fructo, galacto, xylo-, isomalto- soybean, lactosucrose,
raffinose, lactulose and palatinose oligosaccharides (Farnworth, 1997; Sako et al.,
1999).
Oligosaccharides are water soluble and have a relatively low sweetness (about
0.3-0.6 time that of sucrose), which depends on their chemical structure and molecular
mass. For this reason they are used as bulking agents and as carriers for other food
flavours,

natural

or

artificial.

Because

of

their

high

molecular

weight,

oligosaccharides provide increased viscosity, leading to improved body and
mounthfeel (Crittenden et al., 1996; Tamine, 2005). Other applications include the
alteration of the freezing temperature of frozen foods, and the control of the amount of
browning in heat-processed foods. Oligosaccharides have also been shown to be
strong inhibitors of starch retrogradation.
As soluble dietary fibre, oligosaccharides are commonly used as lowcariogenic sugar substitutes in confectionery, jams, pastry, chewing gums, yoghurts,
drinks, and in low calorie diet and diabetic foods (Matsumoto et al., 1995).
Studies regarding the in vitro cariogenicity of trans-galactooligosaccharides
(TOS) (Hartemink et al., 1997) proved that many oral bacteria are able to degrade and
ferment TOS and galactosyl-lactose (GLL). Although lactic and acetic acid are
produced, the fermentation process is relatively slow. Plaque is not formed, so the risk
of caries formation from TOS and GLL is considered rather low.
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The caloric value of non digestible oligosaccharides has been estimated to be
1.0-2.0 kcal/g (Roberfroid et al., 1993). In particular, Watanuki et al. (1996)
calculated the caloric value of GOS as 1.73 kcal/g.
GOS are stable compounds, and they remain unchanged even after high
temperature treatment and are also quite stable during long-term storage at room
temperature.

It

has

been

suggested

that

their

stability

is

better

than

fructooligosaccharides (Voragen, 1998). This property allows their use in thermally
treated foods.
Oligosaccharides are referred as bifidogenic or bifidofactors, referring to their
ability to selectively promote the proliferation of: Bifidobacteria spp. (such as B.
longum, B. breve, B. pseudolongum, B. infantis and B. lactis) and Lactobacillus spp.
(such as L. acidophilus, L. casei, L. reuteri, L. rhamnosus, L. johnsonii, and L.
plantarum) which are believed to be beneficial to intestinal health (Shortt, 1999).
Such bacteria have been described as friendly bacteria or probiotic (from the Greek,
πρo βιοτος, meaning literally ‘for life’). The incorporation of probiotic strains in
traditional food products has been well established in the dairy industry, leading to the
production of novel types of fermented milks and cheeses (Gomes et al, 1999).
Gibson and Roberfroid (1995), defined a prebiotic as a non-digestible food
ingredient which beneficially affects the host by selectively stimulating the growth
and/or metabolism of one or a limited number of beneficial bacterial species already
existent in the colon. Thus, a prebiotic not hydrolyzed and/or absorbed in the upper
part of the gastrointestinal tract, serves as a selective substrate for at least one
beneficial colon bacterial species in such a way as to alter positively the composition
of the microflora.
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Many food ingredients such as non-digestible oligosaccharides, some peptides
and proteins and certain lipids, could act as prebiotics but only the oligosaccharides
are able to fulfil all the criteria of prebiotics as defined above. Oligosaccharides and
specifically, galactooligosaccharides achieve this by acting as a selective carbon and
energy source that “friendly” bacteria can utilize. Organisms such as Escherichia coli,
Clostridium perfringens or Streptococcus mutans, potentially harmful residents of the
gut, cannot utilize GOS (Tomomatsu, 1994). This leads to an improvement of the
balance of intestinal microflora in the gut.
Another strategy in microflora management is the use of synbiotics, in which
prebiotics and probiotics are used in combination (Gibson et al., 1995). The live
microbial additions may be used in conjunction with specific substrate for growth (i.e.
Bifidobacteria with GOS or FOS) (Collins et al., 1999).
There are studies and advances occurring in the medical applications of
specific oligosaccharides. For example, the treatment of gut infectious diseases using
oligosaccharides has been proposed by Playne (2002), who discovered the ability of
specific oligosaccharides to bind to gut mucosal and epithelial surfaces and thus
prevent the attachment of certain microorganisms.
Other investigations established that the presence of Bifidus microflora in the
intestines of breast-fed infants was attributed to the presence of GOS in human milk
(Matsumoto, 1993). Gyorgy (1973) showed that the galactooligosaccharides fraction
of human milk (referred as Bifidus factor) enhanced the growth of Bifidobacteria in
the intestine not only of breast-fed infants but also of infants fed with cow's milk
supplemented with GOS.
Galactooligosaccharides have other potential beneficial effects in addition to
being bifidofactors. Thus they have been reported to:
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-

Help synthesis of B-complex vitamins (B1, B2, B3, B6, B9, B12), produced
by Bifidobacteria strains (Perugino et al., 2004; Kanbe, 1992).

-

Reduce serum cholesterol levels due to assimilation of cholesterol in the
diet by some strains of Lactobacillus acidophillus (Chonan et al., 1995,
Gilliland et al., 1990).

-

Stimulate and enhance mineral absorption of metals such as calcium and
magnesium (Sako et al., 1999). In particular, calcium solubility increases
as a result of SCFA production by Bifidobacteria (Chonan et al., 1995).

-

Affect positively bone mineralization (Chonan et al., 1995; Scholz-Arhens
et al., 2001).

-

Improve blood glucose and triglycerides level (Nakakuki, 2002).

-

Eliminate toxic compounds (Van den Heuvel et al., 1999), such as
ammonia (Tamai et al., 1992).

-

Stimulate intestinal peristalsis as a result of SFCA production thereby,
preventing constipation (Deguchi, 1997).

-

Have anticariogenic activity (Delzenne, 1999).

-

To relieve the symptoms of diabetes mellitus and lactose intolerance (Li et
al, 2008).

-

Prevent colon cancer (Van Dokkum et al., 1999).

GOS are generally recognized as safe (GRAS) as they are components of
human milk and traditional yoghurt products. Acute and chronic toxicity tests showed
no toxicity as well as no mutagenicity for GOS (Sako et al., 1999).
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1.3.1 Galactooligosaccharides dose-response in prebiotic effect
The prebiotic properties of several oligosaccharides have been demonstrated
by the administration of reduced amounts of the products to animals (Kikuchi et al.,
1993; Korpela et al., 1997; Mul, 1997). Caecal enlargement and increases in caecal
contents are common in animals after consumption of GOS. Bouhnik et al. (1997)
compared the in vitro activity of a batch human faecal culture in relation to the
production of adenosine-5-triphosphate (ATP), acid and gas of healthy humans. The
analysis of faeces collected on day 1 (control), 7 days and 14 days after the
administration of GOS found that, in response to added GOS, ATP and acid
production were stimulated. In addition, the rate of increase of acetic acid in the batch
culture in the presence of GOS was higher than that of the control group. This study
suggested that the increase in ATP and acid production was due to the change in
composition of the faecal flora to a bifidobacteria-predominant one.
A human study with galactooligosaccharides and fructooligosaccharides as
prebiotics showed that a daily dose of 4-20 g significantly increases Lactobacilli and
Bifidobacteria levels in the gut (Ryocroft et al., 1999). Similarly, earlier studies by
Tanaka et al. (1983) demonstrated that after a week of intake of β-1→6 GOS at a dose
of 3-10 g/day in healthy adults, the faecal count of bifidobacteria increased in a dosedependent manner. Indeed, a daily intake of 2.5 g of β-1→6 GOS appears to be
sufficient to increase the faecal Bifidobacteria count when the initial baseline level is
low, which is often the case in elderly people (Ito et al., 1993). Boehm et al., (2000)
performed studies in preterm infants where they tested the probiotic capacity of an
oligosaccharide mixture consisting of 90% of galactooligosaccharides and 10%
fructooligosaccharides. A mixture of 1 g/dl of GOS and FOS, similar to the
oligosaccharide content of human milk, cannot stimulate intestinal Bifidobacteria in
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formula-fed infants. However, the number of Bifidobacteria found in the infants fed
with the oligosaccharide mixture was in the upper range of the values found in infants
fed with human milk. Further studies, Moro et al. (2002), demonstrated that a
concentration of 0.4 g/dl of the galacto and fructo oligosaccharide mixture is
bifidogenic and that doubling the amount of oligosaccharides in the feed increased the
effect. Kanamori et al., (2003) also showed that oral administration of a synbiotic
containing GOS (3 g/day) in combination with vancomycin helped to eradicate
methicillin-resistant Staphilococcus aureus (MRSA) and re-established an anaerobicdominant flora in a 3 month old infant suffering from MRSA entercolitis. Deguchi et
al., (1997) showed that bowel habit is improved after daily ingestion of 5 g GOS for a
week. In a study of diabetic subjects with constipation, a correlation was found
between the improvement in constipation and the decrease in faecal Bacteriodaceae
after ingestion of GOS (Narimaya et al., 1996).

1.4 Galactooligosaccharides industrial production
Oligosaccharides and their derivatives play a key role in many biochemical
reactions and their use in therapeutics, as diagnostic tools, in cosmetics and the food
industry is well established (Monsan et al., 1995). The estimated production of non
digestible oligosaccharides in the world grew since the inclusion of GOS in FOSHU:
over 300 products have been approved (Arai et al., 2002), more then half of which
(except for lactulose) are consumed in Japan, with a market value of approximately 10
billion yen (Sako et al., 1999). Furthermore, 60% of FOSHU items so far are products
containing non digestible oligosaccharides. Examples of specific products containing
galactooligosaccharides recently approved are outlined in Table 1.3 (Tamine, 2005).
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Table 1.3: Recent FOSHU introduction containing oligosaccharides (Adapted from
Tamine, 2005).
Claim area
Intestinal
health

Company name
Como
UCC Ueshima Coffee
Nihon Seibutsu Kakagu
Nissin Sugar Manufacturing
Yakult Honsha

Product detail
Croissants with lactosucrose
Powdered soft drink with lactosucrose
Table top GOS
Table top GOS
Soft drink with GOS and polydextrose yogurt with prebiotics
(Lactobacillus gasseri and Bifidobacterium bifidum)

Estimated GOS production in 1995 in Europe was about 15,000 tonnes
(Playne et al., 1996). Examples of companies that are currently involved in GOS
production are Friesland Foods Domo in The Netherlands or Snow Brand Milk
Products in Japan.
Vivinal® GOS (from Friesland Foods) or P7L® GOS (Snow Brand Milk),
whose production process are patented, are used to formulate products targeting
specific groups such as infants, children, women and the elderly. Commercially
available GOS is a mixture of several species of GOS. The typical composition of
Vivinal is GOS (more than ~55%), lactose (~20%), glucose (~20%) and a small
amount of galactose (less than 1%).
Worldwide, there are 12 classes of food grade oligosaccharides in commercial
production and the production in 1995 (latest data available with details from
manufacturers) can be seen in Table 1.4.
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Table 1.4: Yields of produced food-grade oligosaccharides in 1995 by manufacturer
(Adapted from Crittenden et al., 1996)
Class of oligosaccharides
GOS

Estimated
production
in 1995 (t)
15000

Lactulose

20000

Lactosucrose

1600

FOS

12000

Isomaltulose oligosaccharides
Glucosyl sucrose
Maltooligosaccharides

5000
4000
10000

Isomaltooligosaccharides

11000

Cyclodextrine

4000

Gentiooligosaccharides
Soybean oligosaccharides
Xylo-oligosaccharides

400
2000

Major manufacturers

Trade names

Yakult Honsha (Japan)
Nissin Sugar Manufacturing Company (Japan)
Snow Brand Milk Products (Japan)
Borculo Whey Products (The Netherlands)
Morinaga Milk Industry Co. (Japan)
Solvay (Germany)
Milei GmbH (Germany)
Canlac Corporation (Canada)
Laevosun (Austria)
lnalco SPA (Italy)
Ensuiko Sugar Refining Co. (Japan)
Hayashibara Shoji Inc. (Japan)
Meiji Seika Kaisha (Japan)
Beghin-Meiji Industries (France)
Golden Technologies (USA)
Cheil Foods and Chemicals (Korea)
ORAFTI (Belgium)
Cosucra (Belgium)
Mitsui Sugar Co. (Japan)
Hayashibara Shoji Inc. (Japan)
Nihon Shokuhin Kako (Japan)
Hayashibara Shoji Inc. (Japan)
Showa Sangyo (Japan)
Hayashibara Shoji Inc. (Japan)
Nihon Shokuhin Kako (Japan)
Nihon Shokuhin Kako (Japan)
Ensuiko Sugar Refining Co. (Japan)
Asahi Kasei Kagyo Co. (Japan)
Nihon Shokuhin Kako (Japan)
The Calpis Food Industry Co. (Japan)
Suntory Ltd (Japan)

Oligomate
Cup-Oligo
P7L and others
TOS-Syrup
MLS/P/C

Newka-Oligo
Newka-Oligo
Meioligo
Actilight
NutraFlora
Oligo-Sugar
Rafilose and Raftiline
Fibruline
ICP/O
Coupling Sugar
Fuji-Oligo
Tetrup
lsomalto-900
Panorup
Biotose and Panorich
Celdex
Dexy Pearl
Gentiose
Soya-oligo
Xylo-oligo

Both the volume and the diversity of oligosaccharide products are increasing
rapidly as their functional proprieties become better understood (Crittenden et al.,
1996).
There are many foods in which GOS can be included, such as bread and
fermented dairy products. During yeast fermentation and the baking of bread, GOS
are not decomposed and may influence positively the taste and the texture of the
product. Fermented dairy products with Bifidobacteria spp. or other Lactic Acid
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Bacteria (LAB) with added GOS are commercially available in Japan as well as in
Europe.

1.5 Galactooligosaccharides production in a research context
Galactooligosaccharides produced by the action of β-galactosidase on lactose
were identified for the first time in the early 1950s. Four species of GOS were formed
using Kluyveromyces lactis β-galactosidase (Aronson, 1952; Pazur, 1954), and three
using E. coli β-galactosidase (Aronson, 1952). Experiments conducted with high
lactose concentrations detected eleven species of GOS (Roberts et al., 1957). In the
same study, the total concentrations of synthesised GOS was also quite high, as the
hydrolysis of a 35% lactose solution contained up to 44% of the total sugar in the
form of di- and higher- saccharides.
Since then, there have been several studies of the enzymatic synthesis of GOS
by β-galactosidase. The mains findings were that GOS production increased with
initial lactose concentration (Wienbicki et al., 1973; Burvall et al., 1979) and that
GOS production declined as the reaction progresses (Burvall et al., 1980). Also,
different species of GOS were synthesized with different sources of enzyme, 13
Lactobacillus strains showed that each enzyme produced a different spectrum of GOS
(Toba et al., 1981), and more then 20 GOS species were found to be synthesized
using Aspergillus oryzae β-galactosidase (Toba et al., 1985). Yang et al. (1988)
indicated that trisaccharide GOS was formed for all reaction condition studied (lactose
concentrations: 2.5, 5, 10, 15, 20 and 25%), whereas tetrasaccharide GOS was formed
only when the starting lactose concentration was greater than 20%.
A large number of studies to date have shown the formation of GOS using βgalactosidase from different bacteria, such as Candida pseudotropicalis and
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Kluyveromyces lactis (Jeon et al., 1984), S. fragilis (Toba et al., 1978), Escherichia
coli (Huber et al., 1976), Aspergillus oryzae (Betschart et al., 1984) Penicillium
chrysogenum (Ballio et al., 1960) and Bacillus circulans (Mozaffar et al., 1984)
(Table 1.5).
In the tables that follow, the percentage of maximum GOS on initial lactose
used was calculated where possible. Otherwise, the maximum GOS was presented
following the author reference.

Table 1.5: Studies on transglycosylation reaction using lactose as substrate. Where
Lac: lactose, E: enzyme, and Lac0: initial lactose concentration.
Enzyme source

[Substrate]
and/or
[Enzyme] studied

Assay conditions

Saccharomyces fragilis

[Lac]=50, 100, 150,
200, 250, 300, 350,
400 and 500 g/l

T=35°C in phosphate buffer
(0.067M, pH 6.2) for 32 hours

[E]= 0.5 and 0.58%
[Lac]=171g/l

Escherichia coli

[E]=130µg/ml
Bacillus circulans
Candida pseudotropicalis
and Kluyveromyces lactis

[Lac]=45.6 g/l
[E]= 3U/ml
[Lac]=50 and 200 g/l
[E]=1.0-2.0 U/ml

Aspergillus niger

[Lac]=25, 50, 100,
150, 200 and 250 g/l

Maximum
synthesized GOS
(% of [Lac]0)
1.1-21.2%
depending
on
[Lac]

Reference

T=30°C
in
imidazole
hydrochloride buffer (pH 7.2)
with 0.01M NaCl and
0.0067M MgSO4 for 14 hours
T=40°C in buffer (pH 6.0) for
5 hours

~20%

Huber et al.,
1976

6%

Mozaffar
al., 1984

et

T=37°C in phosphate buffer
(0.25M, pH 6.6) for 4 hours
with gentle agitation or at
T=4°C for 24 hours
T=50°C in buffer

11.3-16.3%
depending
on
[Lac] and [E]

Jeon et
1984

al.,

~10%

Yang et al.,
1988

[E]=1.25 mg/ml

Most recent studies of GOS production by β-galactosidase are focused on
improving or maximizing GOS yields from lactose.
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1.5.1 Research on GOS production using thermophilic enzymes.
At high temperature lactose solubility increases and the viscosity of the media
decreases which eliminates the possibility of microbial contamination of the reaction
system. Thus transglycosylation reaction with high lactose content can be performed.
Hence, enzymes that act at high temperatures can be used under conditions that favour
GOS production (Table 1.6).

Table 1.6: Transglycosylation reaction of lactose carried out with thermophilic
enzymes. Where Lac: lactose, E: enzyme, and Lac0: initial lactose concentration.
Enzyme source

[Substrate]
and/or
[Enzyme] studied

Assay conditions

Maximum synthesized
GOS (% of [Lac]0)

Reference

Saccharopolyspora
rectivirgula strain V2-2

[Lac]= 599 g/l

T=70°C in buffer (pH
7.0) for 22 hours

41%

Nakao
1994

et

al.,

T=70°C in sodium
citrate buffer (20 mM,
pH 5.5), with agitation
(400 R.P.M.)

Depending on [Lac]:
~14, 23, 33% for
Pyroc. furiosus
~7, 17, 26 g/l for Sulfol.
solfataricus
~52%
after
optimization of [Lac],
[E], T°C, pH and
reaction time.

Petzelbauer
al., 2000

et

Sulfolobus solfataricus
(SsβGly)
and
Pyrococcus
furiosus
(CelB)
Sulfolobus solfataricus

Thermotoga maritima

Sirobasidium
CBS6803

magnum

[E]=not well specified
[Lac]= 70, 170 and
270 g/l
[E]= 20 U/ml
[Lac]= 300, 400, 500
and 600 g/l
[E]= 1.2, 2.4, 3.6 and
4.8 U/ml
[Lac]= 200, 300, 400
and 500 g/l
[E]= 1.0, 1.5, 2 U/ml
[Lac]= 20 g/l
[E]= 0.25 U/dl

T=70, 75, 80, 85 and
90°C in phosphate
buffer (50 mM, pH
6.0) for 25, 60 and 80
hours
T=50-100°C
in
phosphate buffer (50
mM, pH 6.0) for 360
minutes
T= 60°C in sodium
acetate buffer (100
mM, pH 5.0)

Ha-Young et al.,
2008

~ 10-18% depending on
[Lac] and [E]

Eun-Su
2005

et

al.,

27%

Onishi
1997

et

al.,

For some β-galactosidase, such as Sulfolobus solfataricus, it was found that
GOS production increased linearly with temperature (30-95ºC) (Pisani et al., 1990).
However, temperature did not influence some other enzymes, such as Aspergillus
niger β-galactosidase, as oligosaccharides production was found to be constant
between 8-50ºC (Yang et al., 1988).
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1.5.2 Research on GOS production using immobilized enzymes.
Immobilization is important in commercial enzymology allowing the
repetitive and economic utilization of enzymes (Oliveira et al., 2008). Compared with
free enzyme in solution, enzyme immobilized on a solid support provides many
advantages, including β-galactosidase reusability, continuous operation, controlled
product formation, and simplified and efficient processing (Albayrak et al., 2002). For
these reasons, there are studies focused on the immobilization of enzymes on a
stationary phase while substrate is continually fed through the reaction medium (Table
1.7). Consequently an appropriate immobilized system for transglycosylation is
desirable (Petzelbauer et al., 2000).

Table 1.7: Transglycosylation reactions of lactose carried out with immobilized
enzymes. Where Lac: lactose; E: enzyme; FE: free enzyme; IE: immobilised enzyme,
and Lac0: initial lactose concentration.
Enzyme source

[Substrate]
[Enzyme] studied

Thermus aquaticus
YT-I free (FE) and
immobilized (IE)

[Lac]= 160 g/l

Aspergillus oryzae
free
(FE)
and
immobilized (IE) on
cotton cloth in a
recycle
batch
reactor
Aspergillus oryzae
free
(FE)
and
immobilized (IE) on
mPOS-PVA

[Lac]=43, 133 270 g/l (FE),
2.7 g/l for (IE)

Escherichia coli in
reverse micelles

and/or

Assay conditions

Maximum
synthesized GOS
(% of [Lac]0)
with FE:
-32.8% at pH 6.0;
- 32.4% E at pH 4.6;
with IE:
-32.7% at pH 6.0;
-34.8% at pH 4.6
~ 22% FE,
~ 20% IE

Matella et
al., 2006

T= 30, 40, 60 °C in citratephosphate buffer solution (20
mM, pH 3.5, 4.0, 4.5, 5.0, 5.5)

26.1% FE
26.0% IE

Neri et al.,
2009

T= 37°C in buffer with
338mM
AOT/isooctane,
36mM 2-mercaptoethanol and
0.6mM MgCl2, (pH 4.3–11.2);
T=37°C in aqueous system
with Tris–HCl buffer (0.1M,
pH 7.3)

~ 5-10% depending
on the conditions

Chen et al.,
2003

T=70°C in buffer (pH 4.6, 6.0)
with agitation (60 R.P.M.)

[E]= 100 ml (IE)

[E]= 4.5, 11.8, 23.6 g/l (FE),
5 mg/ml (IE)
[Lac]= 50, 100, 200, 300,
400, 500 g/l
[E]= 0.149 mg/ml (FE), 0.383
mg/ml (IE)
[Lac]=
22.11
g/l
in
AOT/isooctane, 22.11 g/l and
238 g/l in aqueous system
[E]=
16.7
µg/ml
in
AOT/isooctane, 16.7 and 18
µg/ml in aqueous system

T=40°C in acetate buffer (0.1
M, pH 4.5) for 15, 30 and 50
minutes with shaking (150
R.P.M.)
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Kluyveromyces
lactis (Maxilact LX
5000) immobilized
on cotton cloth
Saccharomyces
cerevisiae
L1,
Penicillium
expansum F3 and
Kluyveromyces
lactis
L3
immobilized
in
calcium alginate
Aspergillus oryzae
immobilized
on
cotton cloth

[Lac]= 30, 50, 75, 100 and
125 g/l, pumped at flow rate
2.8 ml/min
[E]= 280U
[Lac]= 50, 100, 180, 270,
320, 380, 450 and 480 g/l
[E]= 10U of immobilized E

[Lac]= 50, 100, 200, 300, 400
and 500 g/l at flow rate 1
ml/min

T= 37°C in potassium
phosphate buffer (0.1 M, pH
6.6) with MgCl2 (1.5 mM) for
60-120 minutes

2-18 mM depending
on [Lac]

Zhou et al.,
2003

T= 37, 45, 50 and 55°C in
acetate buffer (pH 3.6, 4.5,
5.4) and phosphate buffer (pH
6.4, 7.2, 8.2) for 24 hours

28.7%
for
P.
expansum
F3;
28.3%
for
S.
cerevisiae
L1;
23.0% for Kl. lactis
L3;

Li et al.,
2008

T= 30, 40, 50°C in acetic acid
buffer (0.1M, pH 4.5, 5.2, 6.0)
for 11-25 hours depending on
T°C incubation

~ 26%

Albayrak et
al., 2002

[E]= 50 mg/g of cotton cloth

The state of the enzyme (free vs. immobilized) appears to affect GOS
formation. Some authors reported enzyme inactivation during the immobilization
procedure and/or after use versus the free form: ~50-90% on polyethyleneimine and
glutaraldehyde for a β-galactosidase from Aspergillus oryzae (Matella et al., 2006);
~50% on silica-alumina for a β-galactosidase from Kluyveromyces fragilis (Ladero et
al., 2000). This change may be due to mass transfer limitations for the larger sugar
molecules (Yang et al., 1988). On the other hand, some authors (Berger et al., 1995;
Neri et al., 2009; Gaur et al., 2006) did not find significant inactivation of the enzyme
when immobilized or found that the immobilized enzyme gave a higher yield of GOS.
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1.5.3 GOS production using different substrate concentrations or assay
conditions
Other researches have focused their studies on the effect of substrate
concentration on GOS production without changing enzyme concentration or assay
conditions, such as temperature, pH, agitation, reaction time (Table 1.8).

Table 1.8: Transglycosylation reaction carried out with different lactose
concentrations and fixed assay conditions. Where Lac: lactose, E: enzyme Lac0: initial
lactose concentration.
Enzyme source

[Substrate]
[Enzyme] studied

and/or

Kluyveromyces
lactis expressed
in Escherichia
coli

[Lac]= 51.63, 95.84, 301.22
g/l

Bifidobacterium
bifidum NCIMB
41171

[Lac]= 45, 55 g/l

[E]= 0.029 mM

[E]= 2.5% (344U/g)
Bifidobacterium
bifidum NCIMB
41171
Bacillus
circulans
Aspergillus
oryzae
Bifidobacterium
infantis HL96,
expressed in
Escherichia coli
Bifidobacterium
bifidum

[Lac]= 100-500 g/l
[E]= 2x108 c.f.u.
[Lac]=~0.l9-0.59 g/l
[E]= 0.4g in 2 ml H20
[Lac]= 47.57, 90.15, 191.68,
359.97, 571.64 g/l
[E]= 0.1% (4.2 U/ml)
[Lac]= 20-30 g/l
[E]= 2.5 U/ml
[Lac]= 34.23, 85.57, 117.14
and 136.92 g/l

Assay conditions

Maximum
synthesized GOS
(% of [Lac]0)
~ 6-16% depending
on [Lac]

Kim et
2004

~10-17% depending
on [Lac]

Goulas et al.,
2007

5%

Tzortzis et al.,
2005

~20-26% depending
on [Lac]

Boon et al.,
1999

~11-35% depending
on [Lac]

Iwasaki et al.,
1996

T= 30-60°C in Na-phosphate
buffer (50 mM, pH 7.5) for
30 hours with agitation (100
R.P.M.)

6%

Hung et al.,
2002

T= 45°C in sodium citrate
buffer (0.1 M, pH 4.25) for
50 hours

29%

Dumortier
al., 1994

T= 37 °C for 5 hours, in
potassium phosphate buffer
(50mM, pH 7.0), containing
10mM NaCl and 1.5mM
MgCl2
T= 40°C with shaking (100
R.P.M) for 25 hours, in
phosphate buffer (0.1M, pH
6.8) or citric acid/trisodium
citrate (0.1 M, pH 6.2)
T=39°C
in
potassium
phosphate buffer (0.2 M, pH
6.8) for 7 hours
T= 40°C in sodium
phosphate buffer (0.02M, pH
5) for 90-340 min
T= 40°C in pH 4.5 for 15
min

Reference

[E]= 25 µl (50munits)
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Others attempts to improve GOS synthesis examined the effect of lactose and
enzyme concentrations or sources, or assays conditions, such as temperature, solvent
or added metal cations (Table 1.9).

Table 1.9: Transglycosylation reaction carried out with different lactose, and/or
enzyme concentrations, and/or enzyme source, and/or assay conditions. Where Lac:
lactose; E: enzyme; STR: stirred tank reactor; UFMR: ultra filtrate membrane reactor,
and Lac0: initial lactose concentration.
Enzyme source

[Substrate]
[Enzyme] studied

and/or

Kluyveromyces
lactis (Lactozym
3000 L HP G)
Aspergillus
oryzae

[Lac]= 150, 250, 350 g/l
[E]= 3, 6, 9 U/ml
[Lac]= 51.34 g/l
[E]= 0.025 mg (>8U/mg)

Kluyveromyces
lactis (Maxilact
LX 5000)

Bifidobacterium
bifidum
truncated
produced in E.
coli
Kluyveromyces
maxianus var.
lactis OE-20
Sterigmatomyces
elviae CBS8119
Kluyveromyces
lactis (Maxilact
L2000) in stirred
tank
reactor
(STR) and crossflow
ultrafiltration
membrane
reactor (UFMR)

Reconstituted
dried
buttermilk, whose [Lac]=
219 g/l
[E]= 0.1, 0.4, 0.8, 1.2, 1.6,
2%
[Lac]= 100, 200, 400 g/l

Assay conditions
T= 40, 50, 60°C in phosphate
buffer (50 mM, pH 5.5, 6.5, 7.5)
with shaking at 300 rpm
T= 40°C in citrate buffer (50 mM,
pH 4.5) or mixture organic solvent
(1,4-butanediol, 1.5-pentanediol,
methoxyethyl acetate, triethyl
phosphate, acetonitrile) for 48
hours
T= 38°C for 80 min

Maximum
synthesized
GOS
(% of [Lac]0)
~ 5-17.1% depending
on [Lac] and pH
~
0.25-25%
on
lactose substrate at
T0, depending on the
solvent used

Reference
MartinezVillaluenga
et al., 2007
Srisimarat et
al., 2008

~ 13%

Čurda et al.,
2006

T= 38°C for 20 hours

~ 38-42% depending
on the [Lac]

Jørgensen et
al., 2001

T= 25-40°C in phosphate buffer
(10 mM, pH 7.0) for 3 hours

1.5-13% depending
on [Lac] and T °C

Kim et al,
2001

T= 60°C in potassium phosphate
buffer (100 mM, pH 6.0) for 2
hours

24% adding Fe2+,
Zn2+ and Cu2+ in the
media

Onishi et al.,
1998

T= 40°C in potassium phosphate
buffer (0.2M, pH 7.0) with MgCl2
(2mM) for 4 hours with agitation
(200 R.P.M.)

in STR:
~22-25% depending
on [Lac] for [E]=
5.8U/ml in STR;
~ 70-100 mg/ml
depending on [E] for
[Lac]= 340 mg/ml;
in UFMR:
26.05 mg/ml with
[Lac]=250 mg/ml

Chockchaisa
wasdee
et
al., 2005

[E]= not specified, different
[E] used
[Lac]= 10, 39, 50, 100, 200
g/l
[E]= 1.0 U/ml
[Lac]= 20 g/l
[E]= 5 ml of toluene-treated
suspension cells
[Lac]= 220, 280, 340 and
400 g/l in STR, 0.25 g/l in
UFMR
[E]= 2.9, 5.8 and 8.7 U/ml
in STR, 8 U/ml in UFMR
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Penicillium
semplicissimus

[Lac]= 200, 300, 400, 500
and 600 g/l

T= 40, 45, 50 and 55°C in
McIlvaine buffer (75 and 150 mM,
pH 2.6-7.0) for 8 hours

25.63-30-48%
depending on T °C
and [Lac]

Cruz et al.,
1999

T= 40°C for 360 min
- in McIlvaine standard citrate
buffer (0.02 M) pH 4.5 for A.
oryzae and pH 5.0 for B. circulans;

~ 8-15% depending
on the source of the
enzyme

Boon et al.,
2000

A. oryzae: 17-21%;
K. lactis: 21-35%;
Bacillus spp.: 2733%;
K. marxianus ATCC
56497:
~6%
trisaccharides and ~
15% tetrasaccharides

Cheng et al.,
2006

[E]= 18 and 26.6 U
Bacillus
circulans,
Aspergillus
oryzae,
Kluyveromyces
lactis, K. fragilis

[Lac]=~ 0.20-0.60 g/l

Kluyveromyces
marxianus
ATCC
56497,
Kluyveromyces
lactis,
Aspergillus
oryzae, Bacillus
spp.

[Lac]= 330 g/l

[E]= 62.5 mg/ml for B.
circulans and A. oryzae, 100
µl for K. lactis, 75 µl for K.
fragilis

[E]=1% (w/v) K. marxianus,
10 and 13 U/g Lac for K.
lactis, 6.2 U/g Lac for A.
oryzae, 4.5 and 5.6 U/g Lac
for Bacillus spp.

- in potassium phosphate buffer
(0.025 M, pH 7.3) for K. lactis and
pH 6.5 for K. fragilis;
T= 30, 40 and 50°C with agitation
(200-300 R.P.M.) for 24 hours; for
Bacillus spp. 15U gluzyme/g Lac
were added to the β-galactosidase
at 0, 6, 12 and 18 hours and T=
50°C pH 5.0 by adding 40% (w/w)
CaCO3; for K. marxianus 1% (w/v)
of malt extract was added, T= 30
°C pH 5.0-5.5 by 5mM NaOH

Studies on laboratory selected bacterial enzymes have been also carried out
(Table 1.10), without changing the assay conditions (temperature and pH).

Table 1.10: Transglycosylation reactions carried out with selected bacteria or
uncommon strains enzymes. Where Lac: lactose, E: enzyme, and Lac0: initial lactose
concentration.
Enzyme source

[Substrate]
and/or
[Enzyme] studied

Assay conditions

Sporobolomyces
singularis

[Lac]= 200 g/l

T= 40°C in phosphate
citrate buffer (50 mM, pH
6.0)
T= 30°C in buffer (pH 6.0,
with (NH4)2SO4, K2SO4,
KH2SO4, MgSO4, CaCO3)
with shaking for 60 hours.
T= 50°C in McLlvaine
buffer (150 mM, pH 6.5) for
8 hours
T= 37°C
in sodium
phosphate buffer (50 mM,
pH 6.0) for 30 hours

Sterigmatomyces
CBS8119
Penicillium
semplicissimum
Bullera singularis

elviae

[E]= 0.16 U/ml
[Lac]= 400 g/l

[Lac]= 600 g/l
[E]= 26.6 U/50 ml
Pure lactose and whey,
whose [Lac]= 200 g/l

Max
synthesized
GOS
(% of [Lac]0)
~ 35%

Reference

Ishikawa et al.,
2005

~ 37.5%

Onishi et al.,
1995

30.5%

Cruz
1999

et

al.,

34-41%

Cho et
2003

al.,

[E]= 5.4 U/g Lac
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The proportion of transgalactosylation to hydrolysis reactions varies,
depending on different sources of the enzymes. Some β-galactosidases, from E. coli
or Aspergillus niger, appear to promote strong hydrolytic activity, whereas the βgalactosidase from Aspergillus oryzae or Bacillus circulans exhibit strong
transglycosylation (Mahoney, 1998).
From the analysis of most of the present literature until now, it is possible to
conclude that only a few researchers claim to have reached GOS synthesised level
higher than 40%, while most of the research reached a GOS synthesis of around 2025%. The production of higher levels of GOS is a challenge and may require new
approaches.
Although the enzymes derived from various microbial origins have different
properties, many use glutamic acid, as a key catalytic residue of their active site, as
shown in Table 1.11.

Table 1.11: Physical properties and catalytic residues of β-galactosidases from
various microbial origins (Adapted from Zhou et al., 2001).
Enzyme Origin
Molecular weight (Da)
Length (AA)
Proton donor
Nucleophile/base

Kluyveromyces lactis
117618
1025
Glutamate482
Glutamate551

Escherichia coli
116351
1023
Glutamate461
Glutamate537

E. coli (subunits)
118016
1031
Glutamate449
Glutamate512

Aspergillus niger
119160
1006
Glutamate200
Glutamate298

Several β-galactosidases have been purified, sequenced and extensively
characterized. Some β-galactosidases are commercially available. Although there may
be sequence differences in enzymes across species, the active site and the two
catalytic glutamate residues are highly conserved. Thus, fundamentally the problem of
enhancing GOS synthesis is to influence attack of sugar rather then water on the
enzyme-galactose complex.
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1.6 Modelling of GOS production kinetics
Modelling the synthesis of galactooligosaccharides has been investigated in
the past by different authors. Some authors (Iwasaki et al., 1996) considered the chain
length of the synthetised galactooligosaccharides, involving a complex model based
on 19 ordinary differential equations. Although a separation of GOS considering the
chain length is the most complete approach to describe transglycosylation reaction,
from a theoretical point of view, the application of the model could be difficult and
lead to ill conditioned systems (Boon et al., 1999).
Other authors (Boon et al., 1999 and 2000; Neri et al., 2009) proposed
simplified mechanisms, with the consideration of the GOS family of compounds as a
single moiety and ignoring the formation of allolactose or other intermediate
compounds. The solution of the presented models involved the application of the
King-Altman method (King et al., 1956) to simplify the system and reduce the
number of equations. However, the King-Altman simplification lead to a model where
the enzyme concentration is not considered as interactive part of the
transglycosylation reaction.
Kim et al. (2004) proposed a GOS reaction mechanism that included the
enzyme concentration as well as the synthesis of allolactose in the system.
To date, and to the best of our knowledge, no error associated to the estimated
kinetic reaction rates has been reported in literature, other than the values reported by
Neri et al. (2009) and Boon et al. (1999 and 2000). The procedure employed to report
the parameters was to estimate the parameter and its standard error as the mean and
the standard deviation of a series of individual fittings. With present statistical
methods available it would be possible to report statistical errors from individual
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experiments by applying a multiresponse nonlinear regression method (Bates et al.,
1984).

1.7 Overview of the literature on GOS production by β-galactosidase
Although there has been extensive research on better utilization of whey
derived lactose, the dairy industry is still in need of new technologies for converting
lactose into marketable products (Yang et al., 1995). Thus, converting lactose into a
product that contains a prebiotic food ingredient and is free of problems associated
with lactose intolerance is highly desirable (Playne et al., 1996). A recent study (Cho
et al., 2003) comparing the transglycosylation reaction using pure lactose and cheese
whey as substrate, found out that GOS conversion (%) and reaction rate of the whey
reaction were slightly higher with cheese whey than when pure lactose was used as
substrate.
The β-galactosidase most studied for GOS production is from Escherichia coli
and is encoded by the lacZ gene. It is not considered suitable for use in foods owing to
toxicity problems associated with the host coliform (Mahoney, 1997). Hence, the βgalactosidase from E. coli is generally not preferred for use in food industry (Joshi et
al., 1987; Stred’ansky et al., 1993; Mahoney, 2003). Furthermore, many of the
enzymes used in previous studies (Table 1.10) are not from sources commercially
available or are not available in sufficient quantities for industrial applications.
In contrast, relatively little is known about the enzymes from eukaryotes,
such as Kluyveromyces lactis. Previous studies showed that β-galactosidase from B.
circulans produces the largest sized oligosaccharides (Neri, 2008). However, the
enzyme from Kluyveromyces spp. produces comparably large amounts of glucose and
galactose as indicated by its strong hydrolytic activity and production of high
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proportion of trisaccharides in the synthesis mixture (Boon et al., 2000; Matsumoto et
al., 1993; Nakanishi et al., 1983; Prenosil et al., 1987). A recent study (Cheng et al.,
2006) compared GOS production by β-galactosidases from Aspergillus oryzae,
Kluyveromyces lactis and Bacillus spp., in a combined system with K. marxianus βgalactosidases, found that K. marxianus, increasing the final mass production of GOS
by 3%. This is because more GOS-4 and less GOS-2 are obtained by the mixed
enzyme system, as GOS-2 is consumed by K. marxianus, while GOS-4 is not.

1.8 Objectives and aims of the work
The aim of the research in this thesis is to investigate GOS production with
commercially available β-galactosidases with a view to understanding the factors that
influence GOS yield. In order to achieve this the following objectives of the work
were:
•

To propose a model of the reaction system of GOS production that can
be identified under normal conditions.

•

To investigate the effect factors that may influence and improve the
GOS yield. As such the enzyme concentration, substrate concentration
and solvent usage in the kinetics of GOS production were investigated.

•

To investigate the standardisation of GOS production research assays
and the influence of the enzyme source in the GOS kinetics and yield.

The enzymes were obtained from Kluyveromyces spp. and Escherichia coli.
The substrate of the reaction was a waste by-product of the dairy industry, Whey
Permeate. This material has recently been shown to be a good substrate for GOS
synthesis (Cho et al., 2003).
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We sought in the first place to devise an assay method that would allow rapid,
convenient monitoring of the GOS synthesis reaction progress and the quantitation of
key components using Thin Layer Chromatography, TLC.
In order to quantify the GOS synthesis reaction products with greater accuracy
and precision we devised a High Performance Liquid Chromatography (HPLC) assay
method. This allowed accurate quantitation of reaction component profiles that were
used to compare assays under different enzyme and substrate concentrations.
Furthermore, it was possible to examine the effect of enzymes from different species,
such as Kluyveromyces spp. and Escherichia coli, on the GOS synthesis with the aim
of identifying those that gave higher yields.
In order to reduce the water activity of the system, we have examined the
influence of water miscible solvents on GOS synthesis.
Finally, a reaction scheme for lactose hydrolysis and GOS production based
on transglycosylation mechanisms previously described in the literature was proposed
in order to construct a mathematical model of the experimental data. The reaction
mechanism modelling will allow for:
1. The analysis of yield and mass balance and thereby assess the efficacy
of analytical methods to monitor the reaction progress.
2. The estimation of the reaction rate constants for the proposed
mechanism that would facilitate prediction of GOS yield at any point
in time during the reaction.
3. The optimisations of the GOS yield using the model.
4. The assessment of the effect of the manipulation of reaction conditions
(i.e different enzyme/substrate concentration, solvent addition, and
different enzyme source) on GOS production.
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2 Materials and Methods
2.1 Substrates
2.1.1 Whey permeate
The Whey Permeate (WP), used as substrate for GOS synthesis in these, was
provided by Kerry Group plc (Prince’s Street Tralee, Co. Kerry, Ireland). This
product, a fine powder of pale yellow colour, is characterised by a lactose content of
over 90%. The spray dried whey permeate provided was a demineralised WP (product
code W469), whose mineral concentration has been reduced by Ion Exchange. This
product has a lactose content of up to 92%, a protein content of 2.5%, and a fat and
mineral content of 1% each.
The whey was stored in a multi-walled paper sack with inner polyethylene
liner to avoid moisture absorption, and kept in a cool dry store, odour free, with
maximum humidity of 65%. The product is suitable for food industry use.

2.1.2 β-galactosidases
Two β-galactosidases were used to carry out transglycosylation reactions. The
first is commercially available under the name Maxilact® and was provided by
Carbon Group (Ringaskiddy, Co. Cork, Ireland). Maxilact L2000 (G003-MLT-991) is
a purified liquid lactase preparation derived from the dairy yeast Kluyveromyces
lactis. Its activity is ≥ 2,000 Neutral Lactase Units/g. A Neutral Lactase Unit is
defined as the quantity of enzyme that will liberate 1.0 μmol of o-nitrophenol from onitrophenyl β-D-galactoside at pH 7.0 and 37ºC. The enzyme is supplied as a glycerol
solution. The other chemical components present in Maxilact L2000 and its
microbiological properties are listed in the Table 2.0. Maxilact L2000 complies with
the purity specifications of the FAO/WHO’s Joint Expert Committee of Food
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Additives (JECFA), with the Food Chemical Codex (FCC) and with the guidelines for
Food Enzymes of the Scientific Committee of Food (SCF) in the EU.

Table 2.0: Chemical and microbiological properties of Maxilact L2000.
Specification
Heavy Metals
Lead
Arsenic
Mercury
Cadmium
pH
Glycerol
Total bacterial count
Coliforms
Salmonella
Staphyloccoccus aureus
Escherichia coli
Lysteria monocytogenes
Yeasts
Moulds
Antibioticy activity
Mycotoxins

Value
≤ 30 ppm (as Pb)
≤ 5 ppm
≤ 3 ppm
≤ 0.5 ppm
≤ 0.5 ppm
7.0-7.5
≥ 50% (vol/vol)
≤ 10 in 1 ml
≤ 30 in 1 ml
Absent in 25 ml
Absent in 1ml
Absent in 25 ml
Absent in 25 ml
≤ 10 in 1 ml
≤ 10 in 1 ml
Absent by test
Absent by test

The enzyme preparation was stored in its original sealed container at 4ºC, as
specified in the data sheet for the product. Under these conditions the loss of activity
was less then 1% per month.
The second enzyme used in these studies was an Escherichia coli βgalactosidase, purchased from Sigma-Aldrich. The bacterial β-galactosidase, grade
VIII, was a lyophilized powder with an activity of 600-1200 units/mg, where one unit
was defined as the quantity of enzyme that hydrolyzes 1.0 μmole of o-nitrophenyl βD-galactoside to o-nitrophenol and D-galactose per minute at pH 7.3 and 37ºC.
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2.2 Chemicals
All the chemicals, including the chromatography standards: maltotriose,
lactose, galactose and glucose; all solvents, such as ethanol, methanol, butanol,
acetonitrile acetone, diethyl ether, dioxane and sulphuric acid; Thin Layer
Chromatography plates (Fluka, ref. no. 02599); micropipettes (Blaubrand®,
intramark, 1-5 µL, catalogue number 708707); were supplied by Sigma-Aldrich
(Dublin, Ireland).

2.3 Commercially available GOS syrup used for comparison studies
The synthesised products of the reaction were compared with the pre-biotic
galactooligosaccharide syrup commercially available under the name Vivinal GOS®
(Friesland Foods Domo®, P.O. Box 449, Zwolle, 8000 AK, The Netherlands). The
typical composition of this product is 75% dry matter, of which 59% is GOS, 21%
lactose, 19% glucose and 1% galactose. The chemical, physical and microbiological
specifications of Vivinal GOS® are listed in Table 2.1.
.
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Table 2.1: Chemical, physical and microbiological characteristics of Vivinal GOS®.
Where D.M.: dried matter; c.f.u.: colony forming units.
Specifications
Dried matter (D.M.)
Galactooligosaccharides
Nitrogen
Sulphated ash
Lactose anhydrous
Glucose anhydrous
Galactose
Viscosity
Nitrite
pH
Total plate count T=30ºC
Enterobacteriaceae
E. coli
Yeasts
Moulds
Staphylococci Coagulase +
Salmonellae

Value
74-76%
Min 57% on D.M.
Max 0.016% on D.M.
Max 0.3% on D.M.
Max 23% on D.M.
Max 22% on D.M.
Min 0.8% on D.M.
1000-5000 cPs
Max 2 ppm on D.M.
3.2-3.8
Max 3000 c.f.u./g
Absent in 1 g
Absent in 5 g
Max 50 c.f.u./g
Max 50 c.f.u./g
Absent in 1 g
Absent in 25 g

2.4 GOS synthesis reaction
Laboratory scale reactions for GOS synthesis were carried out by dissolving
demineralised Whey Permeate in phosphate buffer (0.1 M, pH: 6.8) to which βgalactosidase at varying levels was added. As indicated by studies in the literature
(Huh, 1990; Lopez-Leiva et al., 1995; Rustom et al., 1998), high lactose
concentrations facilitate transglycosylation reactions. Therefore, the lactose
concentration used was 200 g/l, corresponding to the maximum aqueous solubility of
lactose. In addition to the concentration of 200 g/l, a higher concentration was tested.
A concentration of 350 g/l was reached by adding the Whey Permeate to the buffer
system at its boiling point in order to create a supersaturated solution.
For GOS synthesis reactions were carried out in an Erlenmeyer volumetric
flask immersed in a thermostatic bath (GRANT OLS2000) at 40°C, with agitation at
80 r.p.m., in order to allow for continuous mixing of the media without the formation
of air bubbles.
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Typically, the reactions were carried out in a volume of 100 ml for five hours
to ensure completion of the synthesis/degradation reaction. Triplicate samples (1 ml)
were withdrawn every 30 minutes. The enzymatic reaction was quenched by boiling
for 10 minutes, followed by frozen storage at -18°C.

2.4.1 Use of solvents
Reduced water activity (aw) may enhance the synthesis of GOS (Goulas et al.,
2007). Moreover, many enzymes have altered specificity in the presence of organic
solvents. To enhance GOS synthesis the effect of adding solvents to the GOS
synthesis reaction mixture assay was investigated. The solvents were used in
relatively low concentrations, to avoid inhibiting enzyme activity. The solvents used
were ethanol, acetonitrile, acetone, diethyl ether and dioxane.

2.4.2 Enzyme comparison studies
GOS synthesis reaction was carried out to compare two β-galactosidases from
different sources were carried out. The enzymes compared were E. coli βgalactosidase and Kluyveromyces lactis β-galactosidase (Maxilact L2000). Thus, these
enzymes were sourced from a prokaryote and a eukaryote microorganism. The
reactions were carried out by dissolving demineralised Whey Permeate (200 g/l) in
phosphate buffer (0.1 M, pH 7.0) with agitation (80 R.P.M.). The concentrations used
were 0.1 mg/ml and 0.2% for E. coli and Maxilact L2000 respectively. The initial
rates of lactose degradation were used to normalise the enzymes to the same activity.
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2.5 Methods
2.5.1 pH measurement
pH was measured using an Orion pH meter model 420A (Orion research Inc,
Beverly, MA. US). The pH meter was calibrated with pH 4.0, 7.0 and 10.0 standard
buffers before use.

2.5.2 Water activity measurement
Water activity was measured using an AQUALAB model 3 TE (Decagon
Devices, Inc.), with the temperature of the internal chamber set as the assay
temperature. Before measurement, the water activity of pure distilled water and
activated charcoal were checked.

2.5.3 Thin Layer Chromatography (TLC)
The products obtained through enzymatic hydrolysis of Whey Permeate were
analysed by Thin Layer Chromatography (TLC), using a silica gel matrix on Alu-foil
TLC plate (20x10cm, 60 Å medium pore diameter).
A small portion of the samples (1 µl), was diluted 1:10 and applied to a TLC
plate by capillary injection with a disposable micropipette. The samples were applied
over 1 cm from the bottom of the plate and, at least 1 cm from each other.
Development of the TLC plate was carried out in the Twin Trough Chamber
light-weight CAMAG® (20x10 cm, product number 022.5254, Mason Technology,
Dublin, Ireland), at room temperature, under a fume hood. Before application of
samples the TLC plate was placed in the chamber, which contained the solvent, for
pre-equilibration (Figure 2.0). This step, called conditioning, took 1 hour and helped
to increase the reproducibility of the analysis (CAMAG protocol A 07.3).
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Figure 2.0: TLC development steps. Conditioning is shown on the left and
development on the right (From CAMAG protocol A 07.3).

The solvent system used to separate the carbohydrate mixture, of glucose,
galactose, lactose and galactooligosaccharides, was a butanol/methanol/H2O
(70:20:10 [vol/vol/vol]) mixture.
When development was completed, plates were dried using a Qualivac vacuum
oven at 100 °C and -760 mmHg for 2 minutes approximately. To visualise the
separated carbohydrates the plates they were sprayed with a fine spray of 35% H2SO4
in Ethanol. Finally, the plate was dried in a vacuum oven (100 °C and -760 mmHg)
for 5 minutes.
Since the retention factor depends on many variables, such as temperature and
solvent composition, an internal standard of lactose, glucose and galactose at a known
concentration was spotted on every TLC plate.
The analysis of the plate was achieved by the scanning the developed TLC plate
using a optical scanner (HP series 5300) and subsequent analysis with image analysis
software (Image J, version 1.38X).
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2.5.4 High Performance Liquid Chromatography (HPLC)
High Performance Liquid Chromatography (HPLC) analysis was used to
accurately quantify GOS synthesis products.
HPLC was carried out using a SUPELCOGEL Ca2+ column (product no.
5930-U), 30 cm x 7.8 mm I.D., and a flow rate of 0.5 ml/min. A column heater
(Waters Temperature Control Module I and II) was used to maintain the column
temperature at 80 º C. The column is a cation exchange resin consisting of sulfonated
cross-linked styrene-divinyl benzene copolymer in the calcium form, of 9 μm
particles diameter.
The mobile phase used was distilled, ultrapure water (Waters Purification
System Simplicity 185). The mobile phase was filtered through Nylon filter
(MAGNA 0.22 micron, 47 mm) and degassed for 20 minutes in an ULTRAsonick
bath 57X (NEY) before use.
The detector used was a Refractive Index (RI) Detector (Waters 410), with an
internal temperature of 34 ºC.
For automatic injection, the injection volume used was 10 µl. When the manual
injector was used, 60 µl was injected.
Instrument control, data acquisition and analysis were performed using the
Empower 2 Enterprise Build 2154 (2005, 2006) software.
The samples for HPLC analysis were diluted 1:100 or 1:500 and filtered through
a Nylon membrane (SUPELCO, 25 mm x 0.45µm) before injection.
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2.6 Numerical methods
Model building and individual fitting of data from each of the experiments
were performed using JSim version 1.6.82 (Physiom Project, Washington)
(Bassingthwaighte, 2000).
JSim estimated the values of reaction rate constants by fitting the proposed
kinetic models to the experimental data using a mixture of a non-linear steepestdescent, and an adaptive nonlinear least-squares and SENSOP, a variant of the
Levenberg-Marquardt algorithm (Chan et al., 1993).
The global fitting of the model to the experimental data was performed using
software built in Fortran 77, employing the subroutine DLSODA May 2005 version
of the ODEPACK library (Hindmarsh, 1983) for simulation of the ordinary
differential equations (ODE) system and the multiresponse nonlinear regression
subroutine DODRC from the ODRPACK library (Boggs et al., 1992).
The integration of initial value ODE systems resulting from mathematical
modelling was performed using a multistep backward differentiation formula for stiff
systems in ODEPACK and a implicit Runge-Kutta method of order 5 for stiff systems
(RADAU5) in JSim.
The ODRPACK package used a derivative of the Levenberg-Marquardt
algorithm to perform the fitting of experimental data to a biochemical reaction model.
JSim simulation settings are shown in Table 2.2.
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Table 2.2: JSim simulation constants setting: JSim simulation ODE (a) and JSim
fitting (b).
(a)

JSim simulation ODE
Relative tolerance
Absolute tolerance
Number of steps

Value
10-4
10-7
100000

(b)

JSim fitting
Maximum number of iterations
Min RMS error
Minimum gradient
Parameter tolerance

Value
2000
0.001
10-6
10-8

The ODEPACK package was set with the following options shown in Table 2.3.

Table 2.3: ODEPACK package constants setting.
ODEPACK package
Atoll
Rtoll
Number of steps

Value
10-4
10-7
500000

In the ODRPACK package Jacobian calculation was carried out by a central
differences scheme. The precision of regression estimated automatically by
ODRPACK is shown in Table 2.4.

Table 2.4: ODRPACK precision of regression setting.
ODRPACK package
Significant digits
Tolerance of sum of squares
Parameter tolerance
Maximum number of iterations

Value
up to 8
1.5x10-8
3.6x10-11
10000
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3 Results
3.1 Development of a TLC method for analysis of GOS synthesis
Thin Layer Chromatography (TLC) was initially explored as a screening
technique to monitor the synthesis of GOS. This technique is simple, quick, and
inexpensive. TLC offers the possibility of observing all the components in the
synthesis of GOS at the same time. Thus, under suitable conditions, lactose, glucose,
galactose and GOS may be monitored simultaneously.
Different solvent systems were explored to achieve optimum spot resolution. A
literature review identified several examples of previous studies of TLC analysis of
sugars, carried out using different solvent systems.
For example, Rabiu et al., (2001) separated carbohydrates mixtures, such as
glucose, galactose, lactose and galactooligosaccharides, by TLC using butanolethanol-water (5:3:2 [vol/vol/vol]) as the mobile phase. Petzelbauer el al., (2000),
used 2-methyl-1-propanol/pyridine/H2O (6:4:3) as eluent. Jørgensen et al. (2001) used
a solvent system containing butanol/2-propanol/H2O (3:12:4 [vol/vol/vol]); while
Fischer et al. (2006) achieved separation of oligosaccharides in an acetone/nbutanol/water (70:15:15) mixture. Ohmiya et al., (1977), analysed the products of
lactose hydrolysis with an n-butanol/methanol/boric-acid TLC system (5:3:1
[vol/vol/vol]) at room temperature. The CAMAG protocol (Materials and Methods,
section 2.5.2) advised the use of a mixture of acetonitrile/H2O (85:15) for the analysis
of mono-, di- and trisaccharides and a butanol/methanol/H2O system (50:25:20) for
the separation of polysaccharides.
In our hands, most of those solvent systems were found to yield unsatisfactory
results in terms of resolution, mobility and streaking with the sugars used in this
study. Our optimisation studies showed a solvent system composed of
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butanol/methanol/H2O (70:20:10), achieved good resolution and minimised streaking.
Equilibration of the TLC plate with the solvent system gas phase, prior to
chromatographic development, was essential to achieve good resolution, using the
CAMAG protocol (A 07.3, www.camag.com).
To visualise the separated sugars on the TLC plate, different solutions may be
used, such as: 5% ceric sulphate in 15% concentrated H2SO4 (Rabiu et al., 2001),
orcinol reagent (Jørgensen et al., 2001), anthrone-H2SO4 reagent (Ohmiya el al.,
1977), 5% H2SO4 in ethanol containing α-naphtol (Tanriseven et al., 2002), 3% paraanisaldehyde in ethanol containing 5% H2SO4 (Naudorf et at., 1998),

The

visualization could be achieved either by dipping the plate into the staining mixture
or by spraying it. After several investigations, a solution of H2SO4 in ethanol was
found to be the most appropriate detection mixture for these studies. However the
concentration of H2SO4 was increased to 35% compared to literature protocols
(Tanriseven et al., 2002; Naudorf et al., 1998; Rabiu et al., 2001). The visualization
solution was sprayed on the TLC plates since this method gave a better visualization
than the dipping method.
TLC has been used as a qualitative method to detect galactooligosaccharides
by many authors (Rabiu et al., 2001; Jørgensen et al., 2001; Ohmiya et al., 1977;
Tanriseven et al., 2002; Petzelbauer el al., 2000; Naudorf et al., 1998), but not as a
quantitative method. In this study we investigated the possibility of using this method
to quantify components as they changed during GOS synthesis.
Therefore, qualitative analysis of GOS synthesis was carried out by scanning
TLC plates, followed by image analysis with Image J software. This program allows
quantitative analysis of the spots on the TLC plates which are related to their darkness
and area.
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Standards solutions of glucose, galactose, lactose and maltotriose were spotted
on TLC plates under the previously described conditions (Materials and Methods,
section 2.5.3). The TLC plates showed a linear correlation between the concentration
of the sugars and the darkness and area of the spot (Figure 3.0).
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Figure 3.0: TLC analysis of standard solutions. The densities of the spots of
glucose, galactose, lactose and maltotriose standard solutions are proportional to their
concentrations. Each starting point is a different concentration of a pure standard
solution (line 1: 25 g/l; line 2: 16.6 g/l; lane 3: 12.5 g/l; lane 4: 6.25 g/l; lane 5: 5 g/l;
line 6: 4.16 g/l). The TLC plates were developed with a butanol/methanol/H2O
(70:20:10 [vol/vol/vol]) mixture, stained with a solution of 35% H2SO4 in ethanol and
dried in a vacuum oven (100 °C and -760 mmHg) for 5 minutes.
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Data from the TLC plates shown in Figure 3.0, were used to construct
calibration curves for lactose, galactose, glucose and maltotriose (4.16, 5, 6.25, 12.5,
16.6 and 25 g/l) (Figure 3.1). Each calibration curve was constructed for six
concentration levels, with each concentration spotted in triplicate.
The

response

factor

of

maltotriose

was

used

to

calibrate

galactooligosaccharides. There is not a commercial GOS available for calibration and
because GOS is a heterogeneous mixture, maltotriose was the closest oligosaccharide
to GOS available.
Each TLC plate was run using an internal standard lane to correct for day to
day variations in response to visualization staining. This mechanism allowed the
reduction of the variability of each analysis due to factors such as: quantity of stain
sprayed on the TLC plates, temperature and time of drying. The internal standards
used were: (i) glucose which was used for the glucose calibration; (ii) galactose,
which was used for the galactose calibration; and (iii) lactose which was used as
internal standard for lactose and GOS. The reasons for using lactose as an internal
standard instead of maltotriose is that it represented the variation in the assay in the
same way as maltotriose, and was a cheaper alternative.
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Figure 3.1: TLC standards calibration curves. Galactose, glucose, lactose and
maltotriose curves are the average of the three replicates (± standard deviations). The
linear trend line and relative R2 is shown.
In all cases, calibration curves were linear over the range of concentrations
used. However, it was apparent that the calibrations for monosaccharides were more
reproducible than for lactose and maltotriose. Significant errors were associated with
estimation of maltotriose and lactose concentration in particular.
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3.1.1 Monitoring Maxilact-catalysed GOS synthesis from Whey Permeate by
TLC
The TLC assay method developed was used to monitor Maxilact-catalysed GOS
synthesis form Whey Permeate. Maxilact is a commercial preparation of βgalactosidase from Kluyveromyces lactis, which has been used previously by other
authors for GOS synthesis (Zhou et al., 2003; Čurda et al., 2006; Chockchaisawasdee
et al., 2004). Whey Permeate is not a very common substrate for GOS synthesis, pure
lactose is more commonly used (Tables 1.5-1.10).
Figures 3.2 and 3.3 show a typical TLC plate obtained for the synthesis of GOS
using 0.1, 0.4, 0.8, 1.2, 1.6 and 2% Maxilact and a Whey Permeate solution (200 g/l)
as substrate at 37 ºC over a 5 hour reaction time at pH 6.8. On each TLC plate an
internal standard, composed of lactose, galactose and glucose at a fixed concentration
(Control), has been spotted in the first lane.
The assays with 0.1, 0.4, 0.8, 1.2, 1.6 and 2% Maxilact showed the typical
profile described for GOS synthesis by other researchers (Čurda et al., 2006;
Chockchaisawasdee et al., 2004). It was possible to separate and distinguish all
components during GOS synthesis. The TLC analysis clearly shows lactose
decreasing while GOS, galactose and glucose all increase.
The TLC plates in Figures 3.2 and 3.3, show the influence of enzyme
concentration on GOS synthesis. The reaction was monitored every 30 minutes for 5
hours. For all concentrations used GOS formation was observed within 30 minutes.
The spot corresponding to glucose is clearly visible from the beginning of the
enzymatic reaction and the density of glucose spot is always denser than the galactose
spot. This is consistent with the mechanism of the transglycosylation reaction (Figures
1.4 and 1.6).

57

________________________________________________________Chapter 3: Results
The heterogeneous nature of GOS species gives streaking of its spot in the TLC
plates, making GOS estimation difficult. Resolution of GOS from lactose becomes
more difficult as synthesis progresses (see Figure 3.2 and Figure 3.3). It is clear that
GOS synthesis reaches a maximum whereafter it declines. This is clear that the
enzyme hydrolyses GOS species and that degradation to monosaccharides is favoured
as lactose concentration decline (Figure 3.3). By comparison of Figures 3.2 and 3.3, it
is clear that the hydrolysis process is faster in Figure 3.3 due to the higher enzyme
concentration used.
In conclusion, comparing the assays of GOS synthesis at different enzyme
concentrations revealed similar profiles and showed that the enzyme concentration
influences the rate of the degradation of lactose and as a consequence, the production
of GOS.
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Figure 3.2: TLC analysis of GOS synthesis. Enzyme (E) concentrations: 0.1, 0.4
and 0.8% respectively, using Whey Permeate as substrate. Samples were withdrawn
every 30 min of the 5 hour reaction. Control was an internal standard composed of a
mixture of lactose, glucose and galactose at 16.6 g/l, spotted in the first lane of every
TLC plate. Each starting point is a consecutive sample of the reaction.
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Figure 3.3: TLC analysis of GOS synthesis. Enzyme (E) concentrations: 1.2, 1.6
and 2% respectively, using Whey Permeate as substrate. Samples were withdrawn
every 30 min of the 5 hour reaction. Control was an internal standard composed of a
mixture of lactose, glucose and galactose at 16.6 g/l, spotted in the first lane of every
TLC plate. Each starting point is a consecutive sample of the reaction.
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A comparison of the synthesised GOS in a sample assay (0.4% Maxilact) and
the commercially available GOS solution (Vivinal GOS®) was carried out (Figure
3.4).

Control

Vivinal

Time (min) 0 180

Figure 3.4: TLC comparison of synthesised GOS in a sample assay with a
commercially available GOS source. It can be seen that the retention time of the
GOS in the sample assay is the same of the GOS in Vivinal GOS® solution.

The data from Figures 3.2 and 3.3 were analysed as indicated in Materials and
Method’s chapter (section 2.5.3) and an attempt was made to quantify the changes in
reaction species. The data are shown in Figure 3.5.
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Figure 3.5: Quantitative analysis of GOS synthesis reaction progress. Assays
were carried out in phosphate buffer (0.1M, pH 6.8) with Whey Permeate (200 g/l) at
40ºC, for 300 minutes reaction time; enzyme concentrations used were: 0.1, 0.4, 0.8,
1.2, 1.6 and 2% Maxilact (Where ▲: Lac, ▬: Glc, ٭: Gal, and ●: GOS).
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From Figure 3.5, at 0.1 and 0.4% Maxilact concentrations, it appears that GOS
synthesis reaches a maximum level. At higher enzyme concentrations, it is observed a
maximum in GOS production is observed, followed by a slow decline due to the
hydrolysis of GOS.
Figure 3.6 shows how the enzyme concentrations influence the initial rate of
lactose consumption. By increasing Maxilact concentration, the difference between
the initial lactose and the lactose left after 30 minute of reaction increases.
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Figure 3.6: Influence of enzyme concentration on lactose depletion rate. It can be
seen how increasing doses of enzyme will increase the rate of lactose hydrolysis,
therefore making this an enzyme catalysed reaction.

From these data, it is clear that optimization of GOS production will require a
thorough knowledge of the kinetics of the GOS synthesis reaction in order to identify
the time at which GOS production is optimal for a given level of enzyme.
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3.2 Mathematical modelling of the enzymatic synthesis assays
3.2.1 Full reaction mechanism model
The transglycosylation reaction mechanism could be described by the following
equations (see equations 3.1-3.4 below) (Kim et al. 2004) (this model will be referred
in all further discussion as the full model).
This model was based on the following assumptions:
- Any effect of diffusive transport has not been considered.
- Only one rate-limiting step is involved in the reaction mechanism and all the
other steps are reversible.
- Lactose acts as both a substrate and a glycosyl acceptor, depending on its
concentration.
- Lactose binds the free enzyme to form the E:Gal complex, which interacts
with lactose and glucose for the transglycosylation reaction, but not with
galactose.
- Glucose reacts with the E:Gal complex to form glucose-galactose
disaccharides.
- In order to estimate the molar concentration of GOS a molecular weight of
504.32 g/Mol was assumed estimating a chain of 2 galactose with one
glucose unit.
- The β-galactosidase molecular weight was obtained from BRENDA (TelloSolís et al., 2005) and assumed to be 117619 Da.
The model reaction mechanism is described below in equations (3.1) to (3.4)
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E + Lac
E:Gal

k1
k2
⎯⎯⎯
→
→ E:Gal + Glc
←⎯⎯
⎯ E:Lac ⎯⎯⎯
kr 1
k3
⎯⎯⎯
→
←⎯⎯
⎯
kr 3

E:Gal + Glc
E:Gal + Lac

E + Gal

k4
⎯⎯⎯
→
←⎯⎯
⎯ E + Allo
kr 4

k5
⎯⎯⎯
→
←⎯⎯
⎯ E + GOS
kr 5

(3.1)
(3.2)
(3.3)
(3.4)

Where: E: enzyme; Lac: lactose; E:Lac: enzyme-lactose complex; E:Gal: enzymegalactose complex; Gal: galactose; Glc: glucose; Allo: allolactose.

The material mass balances are described by the following equations (3.5) to
(3.12):

dE
= −k1 ⋅ E ⋅ Lac + k r1 ⋅ E : Lac + k 3 ⋅ E ⋅ Gal − k r 3 ⋅ E : Gal + k 4 ⋅ E : Gal ⋅ Glc − (3.5)
dt
− k r 4 ⋅ E : Gal ⋅ Allo + k 5 ⋅ E : Gal ⋅ Lac − k r 5 ⋅ E ⋅ GOS
dE : Gal
= k 2 ⋅ E : Lac + k r 3 ⋅ E ⋅ Gal − k 3 ⋅ E ⋅ Gal + k r 4 ⋅ E ⋅ Allo − k 4 ⋅ E : Gal ⋅ Glc +
dt
+ k r 5 ⋅ E ⋅ GOS − k 5 ⋅ E ⋅ Gal ⋅ Lac
(3.6)
dE : Lac
= −k 2 ⋅ E : Lac − k r1 ⋅ E : Lac + k1 ⋅ E ⋅ Lac
dt

(3.7)

dGal
= k 3 ⋅ E : Gal − k r 3 ⋅ E ⋅ Gal
dt

(3.8)

dGlc
= k 2 ⋅ E : Lac − k r 4 ⋅ E ⋅ Allo − k 4 ⋅ E : Gal ⋅ Glc
dt

(3.9)

dLac
= k r1 ⋅ E : Lac − k1 ⋅ E ⋅ Lac + k r 5 ⋅ E ⋅ GOS − k 5 ⋅ E : Gal ⋅ Lac
dt

(3.10)
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dAllo
= −k r 4 ⋅ E ⋅ Allo + k 4 ⋅ E : Gal ⋅ Glc
dt
dGOS
= − k r 5 ⋅ E ⋅ GOS + k 5 ⋅ E : Gal ⋅ Lac
dt

(3.11)
(3.12)

The kinetic parameters k1, kr3, k4, kr4, k5 and kr5 are expressed in M-1min-1 and
kr1, k2 and k3 are expressed in min-1.

3.2.2 Fitting of GOS synthesis reaction using the full model

The data obtained from the TLC analysis assays have been modelled using the
full model: equations (3.1) to (3.4).
Figure 3.7 shows a typical fitting of the TLC data using the full model
(equations 3.1-3.5). The full model described the experimental data well.
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Figure 3.7: Measurement and model prediction with full model. HPLC assay with

0.1% Maxilact in WP (200 g/l) is shown. Symbols are the points of experimental data
and lines are the curve fits of the species for the proposed model. Where ○: Lactose;
□: Glucose;

: Galactose and ∆: GOS. Assay conditions are described in Materials

and Methods (Section 2.4).
Table 3.0 shows the fitted kinetic parameters obtained. However, a high
correlation between the kinetic parameters was found and sometimes also a high
standard error (Table 3.0).
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Table 3.0: Fitted parameter values of the enzymatic assays with Maxilact (0.1, 0.4,

0.8, 1.2, 1.6 and 2%) and Whey Permeate (200 g/l). All figures are mean ± standard
deviation.
Parameters
k1 (M-1min-1)
kr1 (min-1)
k2 (min-1)
k3 (min-1)
kr3 (M-1min-1)
lk4 (M-1min-1)
kr4 (M-1min-1)
k5 (M-1min-1)
kr5 (M-1min-1)

0.1%E
200 g/l WP
2052±3
23872±4
3550±4
1.3x103±6 x103
139±2
-15±2
180±3
7.2±1.6
687±3

0.4%E
200 g/l WP
1285±3
25459.1±0.5
4178±2
2859.2±1.7
703.6±1.0
-25±4
0.480±150
3.1±0.9
55 ±7

0.8%E
200 g/l WP
1721±8
25443±11
1388±16
3763±5
419±25
-17±10
86±20
4±1.5
43±7

1.2%E
200 g/l WP
1641±20
25447±10
1268±14
2786±2
375±3
-18±15
100±30
3.6±0.7
48±3

1.6%E
200 g/l WP
1478±6
25458±13
2440±20
2468±2
877±3
-26±30
6.440±7
1.7±0.6
77 ±10

2%E
200 g/l WP
1666±3
25707±3
1580±2
2861±6
406±7
-21±4
92±2
2.1±0.7
50±3

A significant difficulty when modelling of experimental data was encountered.
This was largely due to the large errors associated with TLC measurement which
made reliable estimates of GOS synthesis difficult. However, the TLC method was
useful as a way to monitor trends of the reaction mechanism.
Table 3.1 shows data for TLC analysis of GOS production at 0.4% Maxilact.

Table 3.1: TLC results of the assays 200 of Whey Permeate (WP) with 0.4%

Maxilact concentration. All figures are mean ± standard deviation.
Time
(min)
0
30
60
90
120
150
180
210
240
270
300

GOS
(g/l)
0
48±14
77±28
94±36
115±29
11±7
106±33
102±27
107±23
107±20
95±29

Lactose
(g/l)
198±5
116±22
71±18
40±13
31±9
17±4
14±4
12 ±4
9±5
8 ±4
6±3

Glucose
(g/l)
0
38±12
48±11
56±12
63±13
67±10
75 ±19
73±19
79±20
85±20
91±24

Galactose
(g/l)
0
16±5
23±5
25±1.9
31±2
33±4
37±1.0
37±3
42±5
47 ±11
44±12

Total
(%)
100±5
109±30
111±36
109±41
121±33
161±32
118±38
114±34
120±32
126±32
119±39

The large errors associated with the measurement of GOS species it made
difficult to use the TLC assay for studies of reaction mechanism. In particular, there
was an overestimation of GOS in comparison with literature (Zhou et al., 2003; Kim
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et al., 2004). Based on this, it was decided to develop a HPLC method as a more
precise and accurate way of monitoring the reaction.

3.3 Development of HPLC assay to monitor GOS synthesis
To solve the mass balance problem with TLC assay method, a HPLC method
was devised. HPLC was carried out on a SUPELCOGEL Ca2+ column at 80 ºC, using
distilled, ultrapure degassed water as the mobile phase at a flow rate of 0.5 ml/min.
Components were monitored using a Refractive Index Detector. HPLC analysis gave
more accurate and reproducible quantitation of the species in the GOS synthesis
reaction mixture and a more reliable mass balance. However, the general trend of the
reactions was the same as observed previously by TLC.
The mass balances obtained with the HPLC method have a smaller standard
deviation in comparison with the TLC method. The data obtained in a typical assay
(0.4% enzyme), including the mass balance, are presented in Table 3.2. The total of
the species present in the reaction is within 10% error of the starting value. Thus, the
HPLC assay may be considered a more reliable method than TLC assay for the
quantitation of the changing components of the GOS synthesis reaction. Monitoring
using this assay is expected to yield data that are more suitable for modelling studies.
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Table 3.2: HPLC results of the assays with different concentration of Whey Permeate

200 g/l (a) and 350 g/l (b) with 0.4% Maxilact. All figures are mean ± standard
deviation.

(a)

(b)

Time
(min)
0
30
60
90
120
150
180
210
240
270
300

GOS
(g/l)
3.4±0.6
22.4±0.5
37.5±0.8
29.3±0.3
27.4±1
31.4±1.7
30.7±1.8
29.3±0.9
25.4±0.7
23.8±0.9
21.8±0.4

Lactose
(g/l)
197.9±0.9
108.9±0.3
75.9±0.7
56±3
47.7±1.4
50±2
50±2
46.6±0.6
43.8±0.3
37.3±0.3
38.3±1.1

Glucose
(g/l)
0
52.3±0.3
59.6±1.2
68.3±1.5
66.6±0.8
76.9±1.9
75.2±1.6
76.5±1.9
77±2
76.2±0.8
70.7±0.9

Galactose
(g/l)
0
30.09±0.7
42.5±0.4
49±2
59.1±1.7
50±2
61±2
64.1±0.6
70.5±0.7
74±2
70.6±1.4

Total
(%)
100.0±1.0
106.24±1.0
107.12±1.6
100±3
99±2
103±4
108±4
107±2
108±2
105±2
100±2

Time
(min)
0
30
60
90
120
150
180
210
240
270
300

GOS
(g/l)
5.5±0.1

Lactose
(g/l)
343±4
292.9±1.4
230.4±0.9
187.1±1.9
166.7±0.9
141.9±1.2
136.2±0.6
128.1±1.8
123.8±1.5
118.5±0.3
109.8±0.5

Glucose
(g/l)
0
38.±2
63±2
84.8±1.1
102.4±1.2
109.4±1.1
127.2±1.7
130.5±0.2
131.6±1.7
136.6±1.5
134.2±0.2

Galactose
(g/l)
0
28.4±1.6
39.9±0.8
43.1±0.6
60.2±1.4
57.1±0.9
67.7±1.3
68.0±1.3
70.2±2
76.3±1.3
80.7±1.4

Total
(%)
100.0±0.9
110.7±0.8
113.0±1.5
106±4
113±2
107±4
116±3
116 ±2
115±2
117±2
112±2

26.8±1.4

60.6±0.9
57.9±0.4
66.4±0.7
66.5±1.4
75.3±1.6
79.5±0.5
77.7±1.4
77.2±0.5
68.5±1.1

A typical chromatogram of the standard elution times for a solution of
standards is presented in Figure 3.8. Maltotriose, used as reference for GOS because
of its chemical structure, eluted at 10 minutes, followed by lactose (11 minutes),
glucose (13 minutes) and galactose (14 minutes).
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Figure 3.8: Typical HPLC profile for standards solution. The standard mixture

retention times in minutes were: Maltotriose (Mlt) 9.9808; lactose (Lac) 11.188;
glucose (Glc) 13.017; galactose (Gal) 14.176. Each component of the standard
mixture was present at a concentration of 0.1 g/l. The standard mixture was eluted at
0.5 mil/min using ultrapure, distilled and degassed water as mobile phase on a
SUPELCOGEL Ca2+ column at 80 º C, and a RI detector.

Although baseline resolution of peaks was not obtained, it was possible to
obtain linear standard curves with a smaller standard deviation than those obtained
using the TLC method. That was due to lower variability of HPLC methodology
(Table 3.2, Figure 3.9) and to the favourable HPLC peak resolution (Figures 3.8 and
3.9).
Standard curves for maltotriose, lactose, glucose and galactose were carried
out over a concentration range of 0.01-1.0 g/l (Figure 3.9) using the HPLC analysis
method.
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Figure 3.9: HPLC Standards calibration curves. Galactose, glucose, lactose and

maltotriose are represented as average of the three replicates with their standard
deviations. The linear trend lines, the equations and their relative R2 are also
represented.
A typical chromatogram obtained from a GOS synthesis reaction mixture is
shown below at time 0 and after 210 minutes of reaction (Figure 3.10). Under these
conditions, the first components to elute are oligosaccharides (GOS eluted at 10.69
minutes), followed by disaccharides (lactose eluted at 12.06 minutes), then
monosaccharides (glucose eluted at 14.02 minutes and galactose at 15.28 minutes).
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(a)

(b)

Figure 3.10: Chromatograms of GOS synthesis at different reaction times. Assay

with 0.1% Maxilact in Whey Permeate (200 g/l) at the beginning of the reaction (a)
and after 210 minutes (b). Elution times at the beginning of the reaction: Lactose
12.158 minutes. Elution times, in minutes, after 150 minutes of reaction: GOS 10.69
minutes; lactose 11.335; glucose 13.217; galactose 14.404. Where: Lac: lactose, Glc:
glucose and Gal: galactose. Samples eluted with 0.5 mL/min ultrapure, distilled and
degassed water in a SUPELCOGEL Ca2+ column at 80 º C, RI detector.
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3.3.1 GOS synthesis reaction mixture at different Maxilact and Whey Permeate
concentrations

Enzymatic assays with different Maxilact concentration (0.1, 0.4, 0.8, 1.2, 1.6
and 2%) and Whey Permeate (200 and 350 g/l) were carried out (Figures 3.9, 3.10,
3.11, 3.12).
Comparing Figure 3.5 with Figures 3.11 and 3.12 it is possible to notice that
TLC analysis caused an overestimation of the quantitation of some of the species in
the reaction, especially GOS.
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Figure 3.11: Quantitative analysis of GOS synthesis at different Maxilact
concentrations. Assays were carried out in phosphate buffer (0.1 M, pH 6.8) with

Whey Permeate (200 g/l), at 40ºC, for 300 minutes reaction; enzyme concentrations
used were 0.1, 0.4 and 0.8 % Maxilact. (Where ▲: Lac, ▬: Glc, ٭: Gal, and ●: GOS)
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Figure 3.12: Quantitative analysis of GOS synthesis at different Maxilact
concentrations. Assays were carried out in phosphate buffer (0.1 M, pH 6.8) with

Whey Permeate (200 g/l), at 40ºC, for 300 minutes reaction; enzyme concentrations
used were 1.2, 1.6 and 2 % Maxilact. (Where ▲: Lac, ▬: Glc, ٭: Gal, and ●: GOS)

76

________________________________________________________Chapter 3: Results
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Figure 3.13: Influence of increased lactose concentration on GOS synthesis at
different Maxilact concentrations. Assays were carried out in phosphate buffer (0.1

M, pH 6.8) with Whey Permeate (350 g/l), at 40ºC, for 300 minutes reaction; enzyme
concentrations used were 0.1, 0.4 and 0.8 % Maxilact. (Where ▲: Lac, ▬: Glc,
٭: Gal, and ●: GOS)
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Figure 3.14: Influence of increased lactose concentration on GOS synthesis at
different Maxilact concentrations. Assays were carried out in phosphate buffer (0.1

M, pH 6.8) with Whey Permeate (350 g/l), at 40ºC, for 300 minutes reaction; enzyme
concentrations used were 1.2, 1.6 and 2 % Maxilact. (Where ▲: Lac, ▬: Glc, ٭: Gal,
and ●: GOS)
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Figures 3.11, 3.12, 3.13 and 3.14 showed how the initial substrate
concentration influences both the transglycosylation and hydrolysis reactions. The
synthesis of GOS is increased probably due to the decrease of the water activity in the
media. The water activity of the assays with 350 g/l is 0.968, while the one of the
assays with 200 g/l is 0.984. The influence of initial lactose concentration on βgalactosidase activity is consistent with similar works in literature (Goulas et al.,
2007; Maugard et al., 2003).
By comparing assays with different Whey Permeate concentration, at low
enzyme concentration, i.e. 0.1% (Figure 3.11), it is possible to observe that GOS
synthesis has a increasing trend throughout the reaction time. Furthermore, the
maximum GOS achieved at the end of the reaction is almost doubled by increasing
the starting lactose concentration (Figure 3.13). By increasing enzyme concentration,
i.e. 0.4%, in the assay with 350 g/l, as an increase in GOS synthesis is observed
(Figure 3.13). In the assay with 200 g/l GOS starting with 0.4% of enzyme (Figure
3.11), GOS reached a maximum and then declined. At 0.8 and 1.2% enzyme
concentrations and 350 g/l WP (Figures 3.13-3.14), GOS synthesis starts to decrease
slowly after 4 hours of reaction, while at 1.6 and 2% (Figure 3.14) it decrease after 2
hours. The different trends in GOS synthesis/degradation between the assays with 200
and 350 g/l at the same enzyme concentration may be due to the higher lactose
available as acceptor for the transglycosylation reaction with 350 g/l Whey Permeate.
The trend of GOS synthesis in the assays with 200 g/l Whey Permeate
(Figures 3.11-3.12) is consistent with the results obtained using the TLC assay (Figure
3.5), although the HPLC method shows a lower quantity of GOS production.
The GOS yield, as a percentage of all the sugars present in the media
(GOS%TOT) (Dumortier et al., 1994) (Formula 3.13), has been calculated as the value
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(%) of the GOS present at a certain time of the reaction (GOStx) divided by the sum of
all the other species presents in the media at the same time (Lactx, Glctx and Galtx).

GOS %TOT =

GOS tx
%
( Lactx + Glctx + Galtx )

(3.13)

The degree of lactose conversion (DC) has been defined as a conversion of
lactose to GOS and monosaccharides in percentage (Chockchausawasdee et al.,
2004). It has been calculated as the initial quantity of lactose (Lac0) minus the lactose
present in the solution at a certain time (Lactx) divided by the initial lactose (Formula
3.14).

DC =

Lac0 − Lactx
%
Lac0

(3.14)

In Figure 3.15 the influence of enzyme concentration and Whey Permeate
concentration is related to the GOS % of total sugars and lactose conversion (%). In
the assay with 200 g/l of Whey Permeate, the maximum GOS synthesis (18%) is
achieved when 62% of lactose is converted with 0.4% of Maxilact used. By increasing
substrate concentration to 350 g/l of Whey Permeate, the maximum synthesised GOS
increases to 24%, when 65% of lactose is converted with 0.8% of Maxilact. In both of
the assays, by increasing of the enzyme concentration a higher percentage of lactose is
converted but a smaller GOS percentage obtained. This may be due to a shift of the
equilibrium

of

β-galactosidase

reaction

towards

hydrolysis

rather

then

transglycosylation (Figure 1.6).
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Figure 3.15: Comparison of the effect of enzyme concentration on GOS % of
total sugars at different Whey Permeate concentrations (200 -a- and 350 -b- g/l).

Where: E: enzyme; ■: E 0.1; ■: E 0.4; ■: E 0.8; ■: E 1.2; ■: E 1.6; and ■: E 2%.
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3.4 Model reduction of the GOS synthesis mechanism
3.4.1 Reduced reaction mechanism model

Previous studies (Iwasaki et al., 1996 and Kim et al., 2004) have investigated
the modelling of GOS formation using the full feature mechanism model of reaction.
Generally, this has resulted in an ill-conditioned system, where strong correlation
between parameters and variables has resulted in no statistically meaningful results.
The main approach to avoid this obstacle in this study focused on simplifying the
reaction mechanism and tried to explain GOS synthesis with a reduced set of reaction
steps (Boon et al., 1999 and 2000; Zhou et al., 2003; Neri et al., 2009).
In this work, the GOS synthesis mechanism has been simplified on the basis of
the following considerations based on previous studies by Boon et al., (1999 and
2000) and Zhou et al., (2003):
-

Enzymatic hydrolysis is assumed to be rapidly equilibrated, lumping
therefore the whole enzymatic hydrolysis mechanism into a single first
order step.

-

There is no GOS synthesis inhibition process due to re-arrangement of
the E:Gal complex with glucose by reaction of the E:Gal complex with
glucose, to form allolactose. Therefore the step of allolactose formation
is considered of negligible influence.

From these hypotheses the following system of ordinary differential equations
(ODE) was constructed (equations 3.15-3.17) (this model will be further referred in
the following discussion as the reduced model):
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E + Lac

k1
⎯⎯⎯
→ E:Gal + Glc

(3.15)

E:Gal

k3
⎯⎯⎯
→
←⎯⎯
⎯ E + Gal
kr 3

(3.16)

E:Gal + Lac

k5
⎯⎯⎯
→
←⎯⎯
⎯ E + GOS
kr 5

(3.17)

The material mass balances are described by the following equations (3.18-3.23):
dE
= − k1 ⋅ E ⋅ Lac + k 3 ⋅ E : Gal − k r 3 ⋅ E ⋅ Gal + k 5 ⋅ E : Gal ⋅ Lac − k r 5 ⋅ E ⋅ GOS (3.18)
dt
dE : Gal
= k1 ⋅ E ⋅ Lac + k r 3 ⋅ E ⋅ Gal − k 3 ⋅ E : Gal + k r 5 ⋅ E ⋅ GOS − k 5 ⋅ E ⋅ GOS −
dt
− k 5 ⋅ E : Gal ⋅ Lac
(3.19)

dGal
= k 3 ⋅ E : Gal − k r 3 ⋅ E ⋅ Gal
dt

(3.20)

dGlc
= k1 ⋅ E ⋅ Lac
dt

(3.21)

dLac
= − k1 ⋅ E ⋅ Lac + k r 5 ⋅ E ⋅ GOS − k 5 ⋅ E : Gal ⋅ Lac
dt

(3.22)

dGOS
= − k r 5 ⋅ E ⋅ GOS + k 5 ⋅ E : Gal ⋅ Lac
dt

(3.23)

The kinetic parameters k1, kr3, k5 and kr5 are expressed in M-1min-1 and k3 is
expressed in min-1.
In this reduced model, lactose can react with the galactosyl-enzyme complex
and the synthesis of galactooligosaccharides is assumed to be reversible. Lactose
inhibition, allolactose production (Huber et al., 1976), mutarotation of galactose
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(Bakken et al., 1992), separate production of tri- and tetrasaccharides (Iwasaki et al.,
1996), diffusional limitation and enzyme inactivation with time were not considered
in the model. Also, temperature and pH effects on lactose hydrolysis and
oligosaccharides synthesis were not included (Neri et al., 2009).

3.4.2 Comparison of full model and reduced model set

The kinetics of a general experiment for GOS synthesis (0.1% Maxilact
concentration 200g/l of WP) together with the full model prediction are shown in
Figure 3.16.
Although the full model fitted well the HPLC data (Figure 3.16), the
parameters were correlated highly with large standard errors (data not shown). This
precluded from obtaining sound estimates of reaction rate constants that might be
used to predict GOS synthesis under other conditions.
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Figure 3.16: Measurement and model prediction with full model. HPLC assays

with 0.1% Maxilact in WP (200 g/l) are shown. Symbols are the points of
experimental data and lines are the curve fits of the species for the proposed model.
Where ○: Lactose; ∆: Glucose;

: Galactose and □: GOS. Assay conditions described

in Materials and Methods (Section 2.4).

In Table 3.3 the comparison of the residual sum of the squares between the full
model and the reduced model is shown. It is possible to notice that the reduced model
explained the data at least as well as the full model, with a minor increase in deviance
and a considerable decrease in the correlation between parameters (no parameters
with a correlation higher than 0.95 were found). This indicates that the reduced model
could properly explain the GOS synthesis reaction, even with the elimination of four
kinetic parameters from the nine parameters of the full model.
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Table 3.3: Residual sum of squares of the weighted residuals (RSM) comparison

between the full model -a- and the reduced model -b- of the enzymatic assays with
Maxilact (0.1, 0.4, 0.8, 1.2, 1.6 and 2%) and Whey Permeate (200 and 350 g/l).
(a)

(b)

Substrate concentration
Enzyme concentration
Full Model RSM
Substrate concentration
Enzyme concentration
Full Model RSM

Substrate concentration
Enzyme concentration
Reduced Model RSM
Substrate concentration
Enzyme concentration
Reduced Model RSM

0.1%E
0.197

0.4%E
0.309

0.1%E
0.569

0.4%E
0.808

0.1%E
0.196

0.4%E
0.302

0.1%E
0.567

0.4%E
0.767

200 g/l Whey Permeate
0.8%E
1.2%E
0.189
0.205
350 g/l Whey Permeate
0.8%E
1.2%E
0.713
0.1135

200 g/l Whey Permeate
0.8%E
1.2%E
0.178
0.194
350 g/l Whey Permeate
0.8%E
1.2%E
0.710
0.1135

1.6%E
0.287

2%E
0.344

1.6%E
0.941

2%E
0.958

1.6%E
0.256

2%E
0.313

1.6%E
0.935

2%E
0.957

3.4.3 Fitting of enzymatic assay data with Maxilact and Whey Permeate as
single experiments
Figures 3.16-3.21 show the enzymatic assays carried out with different
Maxilact concentrations (0.1, 0.4, 0.8, 1.2, 1.6, 2%) and/or Whey Permeate (200 and
350 g/l) fitted as individual experiments using the JSim simulation program. From
Figures 3.17-3.22 it is possible to observe that the proposed model explained not only
the lactose hydrolysis, glucose and galactose release but also galactooligosaccharides
synthesis by Kluyveromyces lactis β-galactosidase at various concentrations of
enzyme and substrate. By comparison of the assays with different Whey Permeate
concentration, it is clear that the fitting equations of the model for the assays with 350
g/l of Whey Permeate (Figures 3.20-3.22) show a tendency to underestimate the
glucose concentration. Similar results were found by Boon et al., (1999).
Previously, GOS formation was observed for 5 hours by Iwasaki et al., (1996);
for 12 hours by Neri et al., (2009); for 3.3 and 6.7 hours by Boon et al., (respectively
1999 and 2000); and for 5 hours Kim et al., (2004). The extent of reaction time
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studied in this work of 5 hours is therefore within the context investigated previously
from other authors and it was not considered worthwhile to study the reactions further
since GOS reach a maximum and then started to be degraded (Figures 3.11-3.14).
Another parameter that changes within previous works in literature is the
range of lactose concentrations studied. The reaction kinetics parameters were studied
at different initial lactose concentration:
-

From 0.39 to 1.67M by Iwasaki et al., (1996)

-

0.15, 0.28 and 0.88M by Kim et al., (2004);

-

From 0.19 to 0.59 mol/kg (ca 0.19 to 0.59M) by Boon et al., (1999);

-

Between 0.14 to 1.45M by Neri et al., (2009);

This study covered a wide range of Whey Permeate concentrations, whose
initial lactose content is included between 0.58M and 1.012M. The levels considered,
described the whole reaction up to completion and exhaustion of all lactose in most of
the experiments (Figures 3.17-3.22). However, lactose was not fully depleted in the
assay with 0.1% of Maxilact and 350 g/l of Whey Permeate (Figure 3.20). This is may
be due to diffusional restrictions arising from the viscosity of the system and the small
concentration of enzyme used, both of which delayed GOS formation. Furthermore,
the previously cited works in the literature have covered different lactose
concentrations (Iwasaki et al., 1996; Kim et al., 2004; Boon et al., 1999; Neri et al.,
2009), whereas in the present study, different enzyme concentrations at two levels of
Whey Permeate concentrations have been examined.
Due to the variety of the initial lactose concentrations, quantity enzyme used
and assay conditions by other authors, the maximum GOS achieved in the synthesis
reaction shifts from 0.1 mol/kg (Boon et al., 1999 and 2000) to 0.51M (Neri et al.,
2009) and 0.05M (Kim et al., 2004). In this work, the maximum yield of 0.47M
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(Results, section 3.2.1) was achieved and modelled using the equations proposed
(equations 3.15-3.17).
The results obtained fall within similar conditions to previous investigations of
the GOS synthesis studies carried out. However, differences in the nature of substrate
(Whey Permeate rather then pure lactose), concentration levels of substrate and
enzyme tested and assays conditions could influence the obtained results.
The effect of increasing WP concentration did result in slightly higher GOS
maximum concentrations, with comparable reaction times. Normally higher enzyme
concentrations would result in a shorter time to reach the maximum GOS
concentration, with reaction times of around 50-60 minutes required to reach this
maximum at the higher enzyme concentrations tested.
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Figure 3.17: Experimental measurement of GOS synthesis and prediction of the
individual fitting using the reduced reaction mechanism model. HPLC assays with

0.1 and 0.4% Maxilact in WP (200 g/l) are shown. Points represent experimental data,
where ○: Lactose; ∆: Glucose;

: Galactose and □: GOS, and lines the individual fit.

Assay conditions are described in Materials and Methods (Section 2.4).
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Figure 3.18: Experimental measurements of GOS synthesis and prediction of the
individual fitting using the reduced reaction mechanism model. HPLC assays with

0.8 and 1.2% Maxilact in WP (200 g/l) are shown. Points represent experimental data,
where ○: Lactose; ∆: Glucose;

: Galactose and □: GOS, and lines the individual fit.

Assay conditions are described in Materials and Methods (Section 2.4).
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Figure 3.19: Experimental measurements of GOS synthesis and prediction of the
individual fitting using the reduced reaction mechanism model. HPLC assays with

1.6 and 2% Maxilact in WP (200 g/l) are shown. Points represent experimental data,
where ○: Lactose; ∆: Glucose;

: Galactose and □: GOS, and lines the individual fit.

Assay conditions are described in Materials and Methods (Section 2.4).
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Figure 3.20: Experimental measurements of GOS synthesis and prediction of the
individual fitting using the reduced reaction mechanism model. HPLC assays with

0.1 and 0.4% Maxilact in WP (350 g/l) are shown. Points represent experimental data,
where ○: Lactose; ∆: Glucose;

: Galactose and □: GOS, and lines the individual fit.

Assay conditions are described in Materials and Methods (Section 2.4).
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Figure 3.21: Experimental measurements of GOS synthesis and prediction of the
individual fitting using the reduced reaction mechanism model. HPLC assays with

0.8 and 1.2% Maxilact in WP (350 g/l) are shown. Points represent experimental data,
where ○: Lactose; ∆: Glucose;

: Galactose and □: GOS, and lines the individual fit.

Assay conditions are described in Materials and Methods (Section 2.4).
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Figure 3.22: Experimental measurements of GOS synthesis and prediction of the
individual fitting using the reduced reaction mechanism model. HPLC assays with

1.6 and 2% Maxilact in WP (350 g/l) are shown. Points represent experimental data,
where ○: Lactose; ∆: Glucose;

: Galactose and □: GOS, and lines the individual fit.

Assay conditions are described in Materials and Methods (Section 2.4).
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It can be seen in Figures 3.17 to 3.22 that the individual fitting of the model to
the observed kinetics was good. However, it was noticed a poor prediction of the
model for glucose kinetics was noticeable, especially at higher initial whey permeate
concentrations. This may be due to experimental errors in the estimation of glucose
due to HPLC peak overlapping and to the limitations of the model used, which ignore
any further involvement of glucose in the reaction mechanism. Possible further
improvements of the model and the analytical procedure should consider this,
possibly improving the separation ability of the HPLC assay by the change of mobile
phase.
The kinetic parameters of the reduced model were estimated by using
triplicated data for the enzymatic assays with different concentration of Whey
Permeate (200 and 350 g/l) and Maxilact (0.1, 0.4, 0.8, 1.2, 1.6 and 2%).
By definition, the parameters estimated should be positive since they are
reaction constants in the given direction. Therefore the logarithms of the constants
were estimated by fitting the time-course of lactose conversion data to the proposed
reduced model with JSim (Materials and Methods, section 2.6) (Table 3.4). All the
fitted parameters found were significant.
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Table 3.4: Fitted parameter values of the enzymatic assays with Maxilact (0.1, 0.4,

0.8, 1.2, 1.6 and 2%) and Whey Permeate (200 -a- and 350 -b- g/l). All figures are
mean ± standard deviations.
a

b

Parameters
(log value)
ln(k1) (M-1min-1)
ln(k3) (min-1)
ln(kr3) ( M-1min-1)
ln(k5) (M-1min-1)
ln(kr5) (M-1min-1)

0.1%E
200 g/l WP
4.3±0.7
8.2±1.2
12.8±0.7
1.7±0.9
6.5±1.7

0.4%E
200 g/l WP
10.3±1.1
26.0±0.7
37.7±0.6
6±3
18±4

0.8%E
200 g/l WP
8.4±0.5
10.2±0.4
19.6±0.2
28.8±0.7
37.9±0.9

1.2%E
200 g/l WP
7.9±0.8
7.4±0.7
16.3±0.2
6.9±1.2
15.6±1.2

1.6%E
200 g/l WP
18.3±1.5
8.3±1.2
27.5±0.3
26.7±1.2
45.3±1.8

2%E
200 g/l WP
8.2±1.8
7.1±1.4
16.4±0.4
11.6±1.5
20±2

Parameters
(log value)
ln(k1) (M-1min-1)
ln(k3) (min-1)
ln(kr3) ( M-1min-1)
ln(k5) (M-1min-1)
ln(kr5) (M-1min-1)

0.1%E
350 g/l WP
1.6±0.6
8.2±4
10.5±6
2.5±1.4
3.9±1.4

0.4%E
350 g/l WP
1.2±0.2
6±2
7±2
2.6±0.5
2.1±1.1

0.8%E
350 g/l WP
7.3±1.9
2.9±1.4
11.2±0.6
2.5±0.9
8.8±0.9

1.2%E
350 g/l WP
10.4±1.9
7.1±1.3
18.5±1.0
5.2±0.1
17±9

1.6%E
350 g/l WP
11.3±1.7
10.7±1.3
23±0.8
8±4
21±5

2%E
350 g/l WP
6.1±1.8
6.1±1.5
13.3±0.5
7±4
14±5

Figure 3.23 shows a schematic diagram of the reduced mechanism of GOS
synthesis.

Lac
E
Glc

E

k1

Lac

k5

H2O

E:Gal

GOS
kr5

k3

E

Gal
kr3

Figure 3.23: Schematic representation of reduced model GOS synthesis mechanism.

According to the reduced model mechanism of reaction (equations 3.15-3.17,
Figure 3.23) the four rate constants can be described as follows:
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-

k1 defines the Enzyme:Galactose complex production, which is the
precursor of GOS. The higher this value is, the faster the GOS
formation proceeds;

-

k3 and kr3 are a measure of hydrolysis of the Enzyme:Galactose
complex. The higher the ratio k3/kr3 is, the more inhibition of GOS
formation will occur;

-

k5 and kr5 express the formation of GOS from the Enzyme:Galactose
complex. The higher the ratio k5/kr5 is, the faster GOS are synthesized.

In Figure 3.24 the estimated ln(k1) for all experiments are compared. As can
be seen, in general, experiments at 200g/l show a higher rate of conversion from
lactose to E:Gal complex, indicating that it will take longer for the E:Gal complex to
reach critical concentrations for GOS formation in the 350g/l experiments.
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ln(k1)
25

Value

20
15

200 g/l WP
350 g/l WP

10
5
0
0.1

0.4

0.8

1.2

1.6

2

[Maxilact] (% )

Figure 3.24: Comparison of estimated ln(k1) kinetic parameter for different
initial enzyme and Whey Permeate concentrations. Assay conditions described in

Materials and Methods (Section 2.4). Error bars show the 95% CI for the estimated
parameters from individual experiments.
In Figure 3.25 the ratio of the inhibitory step of GOS synthesis reaction is
plotted for the different experiments performed. It can be seen that inhibition becomes
more important at the lower Whey Permeate concentrations only when intermediate
enzyme concentrations are used. Otherwise, the higher the concentration of Whey
Permeate used, the faster the inhibition of GOS synthesis occurs.
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0
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0.8

1.2

1.6

2
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Figure

3.25:

Comparison

of

estimated

inhibition

kinetics

parameters

ln(k3)/ln(kr3) for different initial enzyme and Whey Permeate concentrations.

Assays conditions described in Materials and Methods (Section 2.4). Error bars show
the 95% CI for the estimated parameters from individual experiments.

In Figure 3.26 the ratio of the GOS formation kinetic parameters is plotted for
the different assays considered. Generally, the assay with the smallest concentration
of Whey Permeate (200 g/l) has the higher ratio ln(k5)/ln(kr5), which indicates that the
GOS synthesis reaction is happening faster than at higher concentrated Whey
Permeate solutions (350 g/l). This is may be due to the increasing viscosity of the
media that results from increasing the concentration of substrate.
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Figure 3.26: Comparison of estimated GOS formation kinetics parameters
ln(k5)/ln(kr5) for different initial enzyme and Whey Permeate concentrations.

Assays conditions described in Materials and Methods (Section 2.4). Error bars show
the 95% CI for the estimated parameters from individual experiments.
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3.4.4 Global fitting of enzymatic assays with Maxilact and Whey Permeate
3.4.4.1 Preliminary screening of data

After observing that the estimated parameters from individually fitted
experiments, the whole set of data for 200g/l (and then 350g/l) was considered for
modelling with a single set of parameter estimates. This will allow us to describe the
mechanism of reaction as a whole and to obtain more precise information about the
reaction parameters.
As a preliminary screening of data to obtain an estimate of a single set of
parameters that would explain all the GOS synthesis performed at the same WP
concentration was carried out. The average glucose (Glc) and galactose (Gal) residue
ratio was calculated for all experiments, based on the sugar residue balance, as
previously shown from Boon et al., 1999:

[Glcresidue ] = [Lac] + [Glc] + [GOS ]
[Galresidue ] [Lac] + [Gal ] + 2 ⋅ [GOS ]

(3.23)

The model used only lactose as substrate; as a consequence the ratio should be
close to 1. An error of 10% was accepted; therefore all experimental data for which
the average ratio was lower than 0.9 or higher than 1.1 the data from the peak with
less confidence, glucose, were removed from the fitting data set.

3.4.4.2 Global fitting of the enzymatic assays with different Whey Permeate
concentrations and Maxilact concentrations

All the enzymatic assays carried out with different Whey Permeate and
Maxilact concentrations levels were modelled in one single fit using the reduced
model previously described (Results, section 3.5.2). For that, the ODEPACK Fortran
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library for simulation purposes and the ODRPACK Fortran library for fitting (see
Materials and Methods, section 2.6) were used. This produced one set of parameters,
which together with the proposed ODE set of equations would be able to describe all
the kinetics of GOS formation.
Global fittings using firstly all data available at 200g/l, secondly all data
available at 350g/l and finally using both sets of data together were carried out. The
multiresponse nonlinear regression procedure converged to a single set of parameters
for the 350g/l and for the global set of data. However, the 200g/l data set regression
was found not to converge. Several attempts were made with different initial
estimates, however no adequate final parameter estimate set was found.
In Figures 3.27-3.30 the global modelling of the assays with 200 and 350 g/l at
increasing Maxilact concentrations are shown. The global fitting to the experimental
data is good for both initial Whey Permeate concentrations employed. The model
always describes accurately GOS synthesis and, in most of the cases, the lactose
depletion and the galactose/glucose release. Because of the data deletion of glucose
(Section 3.5.1) using the glucose/galactose ratio, there is a significant amount of
experiments where the glucose seems to be underestimated, especially when using
350g/l of initial WP. This is not considered a problem of the model, rather a practical
solution to the imbalance observed experimentally in the stoichiometric ratios of
compounds during the reaction.
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Figure 3.27: Experimental measurements of GOS synthesis and prediction of the
global fitting using the reduced reaction mechanism model. HPLC assays with 0.1,

0.4 and 0.8% Maxilact in WP (200 g/l) are shown. Points represent experimental data,
where ♦: Lactose; ▲: Glucose; ●: Galactose and ■: GOS, and lines the global fit.
Assay conditions are described in Materials and Methods (Section 2.4).
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Figure 3.28: Experimental measurements of GOS synthesis and prediction of the
global fitting using the reduced reaction mechanism model. HPLC assays with 1.2,

1.6 and 2% Maxilact in WP (200 g/l) are shown. Points represent experimental data,
where ♦: Lactose; ▲: Glucose; ●: Galactose and ■: GOS, and lines the global fit.
Assay conditions are described in Materials and Methods (Section 2.4).
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Figure 3.29: Experimental measurements of GOS synthesis and prediction of the
global fitting using the reduced reaction mechanism model. HPLC assays with 0.1,

0.4 and 0.8% Maxilact in WP (350 g/l) are shown. Points represent experimental data,
where ♦: Lactose; ▲: Glucose; ●: Galactose and ■: GOS, and lines the global fit.
Assay conditions are described in Materials and Methods (Section 2.4).
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Figure 3.30: Experimental measurements of GOS synthesis and prediction of the
global fitting using the reduced reaction mechanism model. HPLC assays with 1.2,

1.6 and 2% Maxilact in WP (350 g/l) are shown. Points represent experimental data,
where ♦: Lactose; ▲: Glucose; ●: Galactose and ■: GOS, and lines the global fit.
Assay conditions are described in Materials and Methods (Section 2.4).
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The fitting kinetics parameter values of the global fitting of the assays with 200 g/l
and 350 g/l are shown in Table 3.5.

Table 3.5: Global fitted parameter estimates of the enzymatic assays with different

Whey Permeate (200 g/l and 350 g/l) and Maxilact concentrations (0.1, 0.4, 0.8, 1.2,
1.6 and 2%). No convergence was observed for the data at 200g/l. All figures are
estimate ± standard error.
Parameters
(log value)
ln(k1) (M-1min-1)
ln(k3) (min-1)
ln(kr3) (M-1min-1)
ln(k5) (M-1min-1)
ln(kr5) (M-1min-1)

350g/l WP

200 & 350g/l WP

5.84±0.06
1.1±0.3
8.3±0.3
1.37±0.9
8.92±1.0

7.89±0.05
4±6
13±6
0.8±0.6
10.2±0.6

107

________________________________________________________Chapter 3: Results

3.5 Use of solvents in the GOS synthesis reaction
The presence of solvents has been reported to alter the specificity of a number of
enzymes. Thus, we examined the influence of addition of low amounts of solvents to
the GOS synthesis reaction. While some solvents caused partial enzyme inactivation
others did not markedly affect enzyme activity.
The solvents used were ethanol (EtOH), acetonitrile (ACN), dioxane, diethyl
ether, and acetone.
The solvents also lower water activity which may favour GOS synthesis.
However, the solvents influenced only slightly the water activity of the media (Table
3.6); probably due to the small amount added.

Table 3.6: Influence of different solvents (acetonitrile, ethanol, diethyl ether, dioxane,

and acetone) at the same concentration (10%) in Whey Permeate (200 g/l) on water
activity (aw) in comparison to the control. All figures are mean ± standard deviations.
aw WP Control
0.988±0.001

aw WP +

aw WP +

aw WP +

aw WP +

aw WP +

ACN

EtOH

diethyl ether

dioxane

acetone

0.987±0.001

0.987±0.001

0.983±0.001

0.987±0.001

0.985±0.001

It was noticed that some solvents, such as acetonitrile and dioxane, inhibited βgalactosidase activity. Some other solvents, such as acetone and diethyl ether,
permitted β-galactosidase reaction. However, the yield of GOS synthesized in
comparison to the control was not affected (Figure 3.31).
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Figure 3.31: GOS synthesis in presence of different solvents. Average values of

three replicates are reported with relative error bars. Assays were carried out in
phosphate buffer (0.1 M, pH 6.8) with Whey Permeate (200 g/l), solvent (10%) and
0.4% Maxilact, at 40ºC, for 300 minutes reaction. Solvent added were: acetone,
acetonitrile, diethyl ether, dioxane and ethanol. (Where ▲: Lac, ▬: Glc, ٭: Gal, and
●: GOS).
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3.5.1 Fitting of the enzymatic assays carried out with solvents addition

Figures 3.32-3.37 shows the kinetic parameters of the enzymatic assays
carried out with the addition of solvents (10%) in the reaction mixture, composed of
Whey Permeate (200 g/l) and Maxilact (0.4%) fitted as single experiments with the
JSim simulation program. The solvents used were ethanol, acetonitrile, acetone,
diethyl ether and dioxane (see Results, section 3.2.2).
Figure 3.31 shows the changing of ln(k1) between the assays carried out with
solvents. All the solvents, within experimental error, allowed for the formation of
E:Gal complex at the same rate. E:Gal is the precursor to GOS formation. However
acetonitrile and dioxane had slower kinetics, which is consistent with the initial
lactose depletion observed in these assays (Figure 3.31). In Figure 3.32 it can be seen
that the introduction of small concentrations of acetonitrile and dioxane affected
significantly (p<0.05) the initial step of precursor formation in the reaction.
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Figure 3.32: Comparison of estimated GOS formation kinetics parameters ln(k1)
for enzymatic assays carried out with the addition of solvents. Assay conditions

described in Materials and Methods (Section 2.4.1). Error bars show the 95% CI for
the estimated parameters from individual experiments.
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The comparison of the kinetic parameter ln(k3) and ln(kr3) between the
different solvents can be seen in Figures 3.33 and 3.34. The use of organic solvents
resulted generally in a reduction of both ln(k3) and ln(kr3) compared to the control.
This is expected to result in slower degradation of the E:Gal complex towards the
formation of free Galactose. This might have the interesting result of displacing the
reaction towards the formation of GOS, which is characterised by ln(k5) and ln(kr5).
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Figure 3.33: Comparison of estimated GOS formation kinetics parameters ln(k3)
for enzymatic assays carried out with the addition of solvents. Assay conditions

described in Materials and Methods (Section 2.4.1). Error bars show the 95% CI for
the estimated parameters from individual experiments.
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Figure 3.34: Comparison of estimated GOS formation kinetics parameters
ln(kr3) for enzymatic assays carried out with the addition of solvents. Assay

conditions described in Materials and Methods (Section 2.4.1). Error bars show the
95% CI for the estimated parameters from individual experiments.
The ratio between ln(k3)/ln(kr3) (Figure 3.35) shows that the use of dioxane
and diethyl ether reduced this ratio (p<0.05). Therefore the use of solvents had an
observable effect in the balance of the reaction mechanism.
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Figure

3.35:

Comparison

of

estimated

inhibition

kinetics

parameters

ln(k3)/ln(kr3) for enzymatic assays carried out with the addition of solvents. Assay

conditions described in Materials and Methods (Section 2.4.1). Error bars show the
propagated 95% CI for the estimated parameters from individual experiments.

The kinetic parameter ln(k5) (Figure 3.36) did not change between the
experiments taken into consideration. No statistically significant difference between
the different solvents was found.
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Figure 3.36: Comparison of estimated GOS formation kinetics parameters ln(k5)
for enzymatic assays carried out with the addition of solvents. Assay conditions

described in Materials and Methods (Section 2.4.1). Error bars show the 95% CI for
the estimated parameters from individual experiments.

In Figure 3.37 the kinetic parameter ln(kr5) is represented. The assay carried
out with dioxane addition showed a higher value then the other assays (p<0.05).
Hence, in the presence of this solvent, the transglycosylation reaction is shifted
towards the degradation of GOS rather then its synthesis. This is consistent with the
kinetics shown in Figure 3.30.
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Figure 3.37: Comparison of estimated GOS formation kinetics parameters ln(kr5)
for enzymatic assays carried out with the addition of solvents. Assay conditions

described in Materials and Methods (Section 2.4.1). Error bars show the 95% CI for
the estimated parameters from individual experiments.
The ratio between ln(k5)/ln(kr5) (Figure 3.38) showed that the assays carried
out with acetone, diethyl ether and ethanol had the same GOS formation mechanism
as the control.
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Figure 3.38: Comparison of estimated GOS formation kinetics parameters
ln(k5)/ln(kr5) for enzymatic assays carried out with the addition of solvents.

Assays conditions described in Materials and Methods (Section 2.4.1). Error bars
show the propagated 95% CI for the estimated parameters from individual
experiments.
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3.6 Enzyme comparison
Many authors have sought to improve GOS synthesis by the selection of
enzymes that are more efficient than others previously studied. It is generally believed
that yeast enzymes are more suited for industrial processes than bacterial ones
(Rustom et al., 1998; Cheng et al., 2006). However, a central problem with the data
from the literature is that it is difficult to decide whether one enzyme source is better
than another for GOS synthesis. This is due to the fact that different researchers have
used different assay conditions such as temperature, pH, substrate concentration and
enzyme concentration.
Many researchers have claimed that one enzyme preparation is better than
another but have not used a standard that allows easy comparison between
researchers. Where comparisons have been made between enzymes interpretation has
been difficult since the enzymes were estimated at different pH, temperature,
inclusion level –all factors that affect GOS synthesis.
We have explored this issue by attempting to compare two enzymes from
widely different organism: Kluyveromyces lactis and Esherichia coli: one is
eukaryotic, the other prokaryotic.
The DNA sequences are compared through a Basic Logical Alignment Search
Tour (BLAST) search carried out via the ClustalW website. The β-galactosidases
sequences were taken from BRENDA-enzymes database (Chang et al., 2009). As the
Escherichia coli strain used in the Sigma Aldrich preparation is unknown, a consensus
sequence was deduced via the ClustalW website. The alignment file was then plotted
in GENEDOC© (2000) in order to show sequences identities through shading utilities
(Figure 3.39).
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Figure 3.39 Alignments sequences of Kluyveromyces lactis and Escherichia coli
consensus sequence via ClustalW website. Shadows show identities between the

sequences.
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The two enzyme preparations were assayed for GOS synthesis at:
-

same pH (phosphate buffer 0.1 M, pH 7.0);

-

same substrate concentration (Whey Permeate at 200 g/l);

-

same temperature (37ºC);

The enzyme preparation were normalised to the same activity as measured by
initial rate of lactose consumption in the first hour of reaction.
Under these conditions no significant difference in GOS synthesis profile was
observed (Figure 3.40).
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Figure 3.40: Comparison assays with different enzyme sources added
(Kluyveromyces lactis -a- and Escherichia coli -b-). Average values of three

replicates are reported with relative error bars. Assays were carried out in phosphate
buffer (0.1 M pH 7.0) with Whey Permeate (200 g/l) at 37ºC, for 300 minutes reaction
time. (Where ▲: Lac, ▬: Glu, ٭: Gal, and ●: GOS).
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3.6.1 Fitting of the enzymatic assays carried out with different sources of βgalactosidase

The enzymatic assays carried out with different sources of β-galactosidase at
the same conditions (substrate concentration, pH, temperature, time, ionic strength)
have been fitted as single experiments. In Figure 3.41 the comparison of the kinetic
parameters of the enzymatic assays carried out with different sources of βgalactosidase is shown. It can be seen that no parameters are different (p<0.05).
Therefore, using different enzymes normalised to the same activity scale did not affect
the maximum GOS formation, as was observed in the experimental results (Figure
3.40).
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Figure 3.41: Comparison of estimated GOS formation kinetics parameters ln(k1),
ln(k3), ln(kr3), ln(k5) and ln(kr5) for different β-galactosidase sources at the same
assay conditions. Error bars show the 95% CI for the estimated parameters from

individual experiments. Assay conditions are described in Materials and Methods
(Section 2.4.2)
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Figure 3.42 shows the fitting of the enzymatic assays with the reduced model
using the above kinetic parameters. From Figure 3.42 it is possible to see how the
model fitted well the experimental data, especially for lactose degradation and GOS
formation.

121

________________________________________________________Chapter 3: Results

Figure 3.42: Experimental measurements of GOS synthesis and prediction of the
global fitting using the reduced reaction mechanism model. HPLC assays with

0.2% (vol/vol) Kluyveromyces lactis and 0.1 mg/ml Escherichia coli in WP (200 g/l)
are shown. Points represent experimental data, where ○: Lactose; ∆: Glucose;

:

Galactose and □: GOS, and lines the best global fit. Assay conditions are described in
Materials and Methods (Section 2.4.2).
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3.7 Attempts to produce high GOS preparation
Synthesis of GOS reaches a maximum for all enzymes when about 60%
lactose conversion has occurred and subsequently declines (Figure 3.15). It was not
possible to obtain GOS yield higher than 24% (w/w) for any combination of enzyme
or WP concentration assayed (Figure 3.15 b). Preparations high in GOS are of great
industrial interest due to the increasing interest in probiotic preparations for their
functional properties (see introduction, section 1.4). After characterising the reaction
mechanism in previous experimental work, an attempt was made to produce a
carbohydrate fraction enriched in GOS by further processing the reaction mixture.
The following experiments were carried out:
1. Selective enrichment of the GOS mixture by lactose crystallisation.
2. Increase of GOS yield by addition of WP during the reaction mixture.

3.7.1 Lactose crystallization

The first series of experiments attempted to selectively crystallise lactose from
GOS synthesis reaction mixtures. An assay with 0.8% Maxilact and 350 g/l of Whey
Permeate was chosen as the one that gave the highest GOS yield of the all
experiments. At the maximum point of GOS synthesis (90 minutes), the reaction was
quenched by immersing the reaction medium in boiling water. The GOS synthesis
reaction mixture was concentrated slowly using a Rotary evaporator. The objective of
this step was to attempt to induce lactose to crystallise. When 50% of the water was
removed, the solution was divided into 100 ml beakers and stored at 4 ºC and 25 ºC in
order to allow lactose crystals to grow. Further water removal was difficult due to the
formation of viscous syrup. A few seeds of lactose were added to stimulate crystal
formation (Gänzle et al., 2008). The solutions were kept without agitation, until
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further analysis, for three weeks. Contrary to what was expected, none of lactose or
other sugars in the two solutions did crystallise. Prolonged evaporation was used
concentrate the GOS synthesis reaction mixture. This caused the thickening of the
syrup and no crystalline material was observed. The negligible lactose crystallization
might have been due to presence of other sugars in the solutions and the high viscosity
of the solution itself (Ibarz et al., 2002). At the moment, there are no studies regarding
the effects of glucose, galactose and GOS, simultaneously, on lactose crystallization.
A HPLC analysis of the concentrated solutions was carried out. The
concentrated solutions presented a higher concentration of GOS, as well as the other
species in solutions, i.e. lactose, glucose and galactose but the ratio of species was the
same as for the control (Table 3.7).

Table 3.7: Influence of water removal on GOS content. Where Lac: lactose; Glc:

glucose; Gal: galactose.
Sample
0.8% E + 350 g/l WP
(Control)
0.8% E + 350 g/l WP After
rotavapor stored at 4 ºC
0.8% E + 350 g/l WP After
rotavapor stored at 25 ºC

GOS (g/l)

Lac (g/l)

Glc (g/l)

Gal (g/l)

GOS Yield

68.614

100.266

119.389

70.797

23.623

93.152

184.716

211.550

93.152

19.033

93.839

190.026

213.549

93.840

18.865

From Table 3.7 it is possible to observe that the two different storage
temperatures did not influence lactose crystallization.
It was assumed that lactose crystallization in the analysed systems will
eventually occur; however the time scale necessary to let lactose crystals form is not
compatible with industrial application. Therefore other approaches to increase GOS
yield were examined.
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3.7.2 Addition of Whey Permeate

The results obtained comparing assays with different Whey Permeate
concentrations indicated that high concentrations of substrate enhanced GOS yield
(Results, section 3.2.1). Therefore an attempt to add Whey Permeate to the synthesis
mixture at the maximum point of GOS synthesis was made. The reaction mixture used
for this study was 0.8% Maxilact and 350 g/l of Whey Permeate. A quantity of Whey
Permeate solids was added to that synthesis mixture (70 g in 100 ml) after maximum
GOS concentration was achieved (90 minutes) and stirred to facilitate its dissolution.
It was not possible to dissolve all the Whey Permeate powder, due to the low
solubility of lactose and the fact that it was not possible to bring the solution to its
boiling point since this would have caused complete enzyme denaturation.

The

reaction component profile of the sugar species for the assay with addition of Whey
Permeate are presented in Figure 3.43.
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Figure 3.43: WP addition at 90 minutes of the enzymatic assay. Assay was carried

out in phosphate buffer (0.1 M, pH 6.8) with Whey Permeate (350 g/l) and 0.8%
Maxilact, at 37 ºC, for 5 hours reaction time. After 90 minutes from the starting of the
reaction Whey Permeate (70 g/100 ml) was added (arrow) (Where ▲: Lac, ▬: Glu, ٭:
Gal, and ●: GOS).

The Figure 3.43 shows that by adding more substrate to the reaction mixture at
the point of maximum GOS synthesis initially induces an increase in GOS levels,
which thereafter slowly decreases. The maximum GOS yield achieved was 22%
(w/w) in comparison to the 24% (w/w) of the control.
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4 Discussion
The synthesis of galactooligosaccharide from lactose, using β-galactosidases,
has been extensively investigated over the last 50 years due to the functional
properties of GOS as prebiotics (Tanaka et al., 1983; Hidaka et al., 1986 and 1988;
Kunz et al., 1993; Champ et al., 2003). The interest in GOS synthesis has increased
since its inclusion in Japanese legislation regarding foods for specified health use
(Farnworth, 1997).
Many researchers have investigated the GOS synthesis reaction, with the
objective of increasing the final GOS yield by changing β-galactosidases sources
and/or synthesis conditions (Tables 1.5-1.10). However, most of the literature on GOS
synthesis achieves a maximum GOS yield of 20-24% and only a few laboratories
report yields higher than 40% (Tables 1.5-1.10). Variability in GOS yield may be
influenced by several factors:
•

competition between hydrolysis and transglycosylation at the βgalactosidase active site (Figures 1.4 and 1.6);

•

low lactose aqueous solubility (Hunziker et al., 1962);

•

the inhibitory effects of monosaccharides released during the reaction
(Bakken et al., 1992; Shin et al., 1998);

•

the viscosity of concentrated lactose solutions that slow the reaction
kinetics (Iwasaki et al., 1996).

In the present work, optimisation of GOS synthesis was examined for
application on an industrial scale. A TLC and a HPLC assay method were used for
analysing GOS synthesised by the enzymatic assays with β-galactosidases. A
literature review showed that these analytical techniques are amongst the most widely
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used in the field of GOS analysis, due to their short analysis time and the simple
laboratory instrumentation required. This makes bench scale application and the study
of reaction kinetics possible.

4.1 Analysis of GOS synthesis by TLC assay method

At the outset of these studies we attempted to devise a rapid, quantitative assay
based on separation of GOS synthesis reactants and products by TLC.
We showed this analytical method could be successfully used for quantitation
of individual components. However, problems with the precision and accuracy of this
analytical method were encountered:
•

The precision of analysis of some components (e.g. GOS and glucose)
were better for others (i.e. galactose and lactose) as can be seen in
Table 3.1. This may be due to differences between TLC plates that
produce variations in separation and staining.

•

When comparing the results obtained with TLC analysis against
similar results in the literature, it was observed that the TLC method
produced a biased result, with overestimation of GOS production
(Zhou et al., 2003; Kim et al., 2004). The lack of complete separation
between GOS components and lactose may have caused this loss of
accuracy.

Attempts were made to improve TLC plate variation by taking into account
the differences in background staining between plates by the inclusion of internal
standards to correct for run to run variation. Attempts were also made to improve
resolution of the TLC method by examining a wide variety of solvent systems to
improve separation and by examining different spot visualisation methods. Despite
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screening a number of different configurations of solvent systems and staining
methods, significant problems in precision and accuracy remained.
However, TLC allowed the analysis of more than thirty samples per day and
therefore facilitated the screening of trends in the kinetics of the enzymatic reactions.
Using the TLC assay, GOS synthesis from Whey Permeate was confirmed through
comparison with commercially available GOS preparation Vivinal GOS® (Figure
3.4). The effect of enzyme concentration on the maximum GOS yield was also
observed in these TLC studies (Figure 3.5). This has been previously reported by
other authors (Čurda et al., 2006; Chockchaisawasdee et al., 2005).
The TLC method could have been improved by increasing the length of the
TLC plate or by running the TLC plate twice. However, this would have doubled the
analysis time, reducing the sample throughput. It is possible that this method may be
used quantitatively in the future if conditions for separation of components can be
improved. The method does accurately measure release of monosaccharides and
might be useful for kinetic studies of the GOS synthesis reaction. Further attempts at
optimising this assay method were abandoned in favour of a HPLC-based assay.

4.2 Analysis of GOS synthesis by HPLC

A HPLC solvent system was devised, that separated the components of the
GOS synthesis reaction and allowed a more precise (Figure 3.9) and accurate (Figure
3.10) quantitation of GOS components. Despite many attempts, a baseline separation
of glucose, galactose, lactose and GOS was not achieved. This was the best separation
obtained considering the time and the resources available. However, separation
between the components was sufficient to allow their accurate quantitation during
GOS synthesis. A comparison between data derived by TLC analysis and data
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obtained by HPLC analysis showed that the former greatly overestimated the level of
GOS and galactose production and underestimated the lactose concentration.
Difficulties in accuracy of quantitation of carbohydrates in complex mixtures
may account for some of the variation in GOS yield reported in the literature. The
precision of yield data for GOS synthesis in the literature is difficult to assess since
few reports show chromatograms of GOS synthesis mixtures and many do not give
estimates of errors associated with GOS measurement which are presented in the form
of error bars in only a few reports (Martínez-Villaluenga et al., 2008; Li et al., 2008).
In our hands it was clear that TLC-based methods can greatly overestimate GOS
synthesis yield compared to the HPLC method.
The differences between the two analytical methods were highlighted by
attempts to model the reaction progress curves. High levels of error in parameters
were associated with TLC derived data.
A study of enzymatic assays with different concentrations of Maxilact® βgalactosidase (0.1, 0.4, 0.8, 1.2, 1.6 and 2%) and Whey Permeate (200 and 350 g/l)
was carried out. The results showed the clear influence of initial enzyme
concentration on GOS yield as well as its speed of synthesis and degradation, as
previously observed by other authors (Čurda et al., 2006; Chockchaisawasdee et al.,
2005). High enzyme concentrations led to rapid GOS synthesis but also to its rapid
degradation. Initial substrate concentration influenced GOS formation, consistent with
previous studies (Goulas et al., 2007; Maugard et al., 2003). Higher initial lactose
concentrations increased the transglycosylation reaction to favour GOS synthesis
rather then monosaccharides formation. A yield analysis of GOS synthesis reactions
led us to obtain an optimum GOS yield of 24% using 0.8% of Maxilact and 350 g/l,
Whey Permeate (Figure 3.15).
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4.3 Effect of solvent addition on GOS synthesis

A study of solvent addition on the enzymatic synthesis of GOS was carried
out. Low solvent concentrations (10%) were tested in order not to inhibit the βgalactosidase action. The solvents used were acetone, acetonitrile, ethanol, diethyl
ether and dioxane. These solvents were chosen after a review of previous work in the
literature on the effect of solvents on β-galactosidase activity (Yoon et al., 2005;
Giacomini et al., 2002). In comparison to the assay without solvent addition, it was
observed that some solvents inhibited β-galactosidase activity (dioxane and
acetonitrile) while other solvents (acetone, diethyl ether and ethanol) gave similar
profiles to the control (Figure 3.31). Further work on the effects of solvents on the
transglycosylation reaction, especially of ethers would be of considerable interest. The
reduction of water activity by diethyl ether (Table 3.6) and the low polarity of those
compounds may avoid β-galactosidase inactivation (Yoon et al., 2005).

4.4 Comparison of different sources of β-galactosidase

A significant effort, as judged by the number of literature reports, has gone
into finding enzymes that will enhance the yield of GOS. It is generally believed that
certain enzymes (from yeast) are better than others (from bacteria) at catalysing GOS
synthesis (Rustom et al., 1998).
In selecting the best enzyme for GOS synthesis the studies in the literature are
confusing (Table 1.5-1.10). Thus, it is almost impossible to compare studies with
different enzymes since they are carried out under different conditions of pH,
substrate concentration, enzyme activity, temperature and ionic strength, all of which
might be expected to influence GOS production. To address this issue we have
compared GOS synthesis for two enzymes under identical conditions of pH, ionic
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strength, and temperature and substrate concentration. Crucially, the two enzymes
were compared at the same level of catalytic activity. This was achieved by using a
quantity of each enzyme that gave the same initial rate of lactose depletion using the
HPLC assay method. The enzymes were selected such that they had a significant
difference in primary sequence. Despite β-galactosidases having different origins and
properties, the active site of β-galactosidases are highly conserved. It has been shown
that the key residues of the catalytic site for microbial β-galactosidases are a pair of
glutamic acid residues (Table 1.11, Zhou et al., 2003). BLAST analysis revealed the
two enzymes used in this study, one prokaryotic, the other eukaryotic, were ca. 40%
identical (Figure 3.39).
Under the conditions used here we found that when these enzymes were
compared directly, there was no significant difference between them in terms of GOS
synthesis profile (Figure 3.39). This study is preliminary and should be extended to a
greater number of enzymes. Nonetheless, it raises the possibility that the differences
between enzymes in GOS synthesis profiles may be related more to factors such as
assay conditions and the specific activity of the enzyme preparations rather than
inherent differences in selectivity.
GOS synthesis is clearly, from Figure 3.23, a competitive process with
hydrolysis. Thus, the enzyme-galactosyl complex caused by lactose binding to βgalactosidases may either react with water or an alternative acceptor. It is difficult to
envisage how an enzyme might be selected that favoured the alternative acceptor.
Water is a less bulky and more mobile species than dissolved carbohydrates. The
active site is necessarily open in order to accommodate the bulk of lactose. Therefore,
it seems likely that competition between these reaction pathways is mainly influenced
by thermodynamic factors such as lactose concentration and water activity. Many
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enzymes may catalyse this reaction with equal efficiency. Further analytical
developments in addition to further enzymatic studies are needed to establish this
point but preliminary evidence supports this conclusion.

4.5 Optimisation of GOS yield

From the arguments above, it is clear that manipulation of water activity,
lactose concentration and reaction products may enhance GOS synthesis. Many
studies have shown that elevated lactose concentrations increase GOS yield (Goulas et
al., 2007). Unfortunately, the attainable lactose concentrations are limited by its low
water solubility. Furthermore, increased viscosity of the reaction medium at high
lactose levels may slow the reaction kinetics, delaying the reaction time at which
maximum GOS is achieved. Relatively few studies have attempted to reduce water
activity as a method to enhance GOS synthesis. The effect of agents such as solvents
on GOS synthesis has also been little explored and was mostly focused on βgalactosidase inactivation (Yoon et al., 2005). Another strategy: the removal of
products by separation techniques has been attempted, but methods for separation are
complex and expensive and are not suitable for large scale industrial application.
We attempted to isolate a high GOS fraction for commercial application by
selective crystallization of lactose. This sugar is known to crystallise readily in a
number of food systems. This work did not yield crystals due to the formation of an
high viscosity syrup when water was evaporated from GOS synthesis reaction
mixtures. This syrup seemed to inhibit crystal formation. This work was preliminary
and did not consider a wide variety of crystallisation conditions. Further efforts in this
area might prove rewarding.
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4.6 Mathematical modelling of GOS synthesis reaction
4.6.1 Full model applied on TLC data

The GOS synthesis reaction was modelled based on a mechanism (equations
3.1-3.4) described by Kim et al. (2004). The GOS synthesis reaction model had been
previously modelled in the literature using the King-Altman transformation (Boon et
al., 1999 and 2000; Neri et al., 2009). However, in the present work, the King-Altman
transformation could not be used since an effect of enzyme concentration on GOS
yield was observed (Figure 3.5). Therefore, the model of Kim et al. (2004) was
chosen to fit the experimental data, since it considered enzyme concentration as part
of the mechanism and had the most complete set of hypotheses. The model fitted the
experimental data well (Figure 3.7), but precision problems arising from high standard
deviations in the estimates of parameters and kinetic parameters with large correlation
led to the search for a reduced model. Generally, a correlation higher than 0.95
between kinetic parameters will generate doubts about their estimation and associated
errors (Donaldson et al., 1987).

4.6.2 Reduced model applied to HPLC data

The experimental data obtained with the HPLC assay were initially fitted
using the aforementioned mathematical model (equation 3.15-3.17), based on that of
Kim et al. (2004). Some GOS synthesis models previously proposed in the literature,
i.e. Iwasaki et al. (1996), Zhou et al. (2003), used a high number of parameters in the
model - up to nine parameters in some cases. In the present work, a simplified
mathematical model was proposed, using a smaller numbers of reaction steps and with
five parameters, to explain the transglycosylation reaction. This reduced reaction
mechanism avoided an ill-conditioned model. The reduced model was based on some
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considerations that emerged on the basis of a literature review of GOS reaction
modelling (Boon et al., 1999 and 2000; Zhou et al., 2003). The simplifications we
employed considered a rapid interaction between lactose and the active site of the
enzyme, which was considered as an irreversible step. Allolactose formation, as an
intermediary step of GOS formation (Jobe et al., 1972), was assumed to be of
negligible influence. The reduced model obtained, and its simplifications, was similar
to other models in literature (Boon et al., 1999, 2000; Neri et al., 2009).
The reduced model was shown to have the same precision as the full model
and also a considerably lower degree of correlation between parameters (Table 3.3).
The experimental data obtained from GOS synthesis with different Maxilact and
Whey Permeate concentrations was fitted both as single experiments and as a global
set of data.
The individual fitting of the enzymatic assays with the reduced model (Figure
3.17-3.22) gave a good prediction of the reaction mixture changes during GOS
synthesis by β-galactosidase. The kinetic parameters obtained through the data
modelling as single experiments were always significant (Table 3.4). From a study of
the individual fits, excluding some outliers, there might be a unique set of parameters
that would fit all the experimental data obtained.
To estimate general kinetic parameters for the whole transglycosylation
reactions studied, a global fitting of the experimental data available was carried out.
Data screening was applied by considering the ratio between the residual glucose and
galactose present in the synthesis mixture, as previously shown by other authors
(Boon et al., 1999). This system allowed the elimination of experimental data with an
error greater than 10%, in order to yield a more homogeneous set of data.
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The global fitting was firstly applied by separating the data sets on the basis of
initial WP concentration, and then by considering all the data together. The estimation
of the assays with 200 g/l Whey Permeate did not converge to a meaningful result.
The global fitting of all the data showed a good fit for both of the initial WP
concentrations used, especially for the synthesised GOS (Figures 3.27-3.30). In the
fitting of all the data, two kinetic parameters gave a high standard error (Table 3.5). In
order to obtain more information about these parameters further experiments are
needed using changing substrate/enzyme concentrations levels. The set of fitting
kinetic parameters obtained with 350 g/l WP is not significantly different to the 200
and 350 g/l in the global model, with the exception of ln(k1). This result might
indicate the necessity to analyse the data using a model that could consider differences
between assays with 200 g/l WP and 350 g/l in ln(k1).

4.6.3 Reduced model applied to experiments in the presence of solvents

The reduced model GOS synthesis mechanism (equation 3.15-3.17) was used
to fit the GOS synthesis profiles in the presence of solvents. The ratio between
ln(k3)/ln(kr3) (Figure 3.35) indicated that the relative importance of the hydrolysis of
E:Gal complex (a GOS precursor) had been reduced in the presence of dioxane and
diethyl ether. The ratio between ln(k5)/ln(kr5) (Figure 3.38) for the experiment with
dioxane was found to be significantly smaller than for the other assays carried out.
This may explain the lower level of GOS production in the presence of dioxane
(Figure 3.31). The ratio between ln(k5)/ln(kr5) (Figure 3.38) showed that reactions in
the presence of acetone, ethanol and diethyl ether are not significantly different from
the control (Figure 3.31). Considering the predicted kinetic parameters for hydrolysis
of the E:Gal complex (Figure 3.35) versus GOS formation (Figure 3.38), it is clear
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that GOS formation is enhanced in organic solvents such as acetone and diethyl ether.
On the basis of these results, future work at increased solvent concentrations may be
of interest. The effect of low polarity solvents on the transglycosylation reaction may
also be interesting to explore (Yoon et al., 2005).

4.6.4 Application of reduced model to comparison of β-galactosidases

The fitting of the experimental data for both β-galactosidases using the
reduced model (equations 3.15-3.17) showed no significant difference between them
for kinetic parameters of the GOS synthesis reaction. A fundamental point to note is
that the β-galactosidases have been employed under identical conditions. If two
enzymes are compared at different pH/temperature, it is not possible to deduce
whether any improvement in the GOS yield may be ascribed to the enzyme source or
to the pH/temperature or other differences in assay conditions.
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5 Conclusions
The present work showed that GOS synthesis from β-galactosidase activity on
Whey Permeate is possible. Enzyme and substrate concentration together with solvent
were factors which were shown to significantly affect the level of GOS synthesised,
while the enzyme source did not. GOS reaction kinetics could be described by a
simple reaction mechanism, which allowed the prediction of GOS synthesis kinetics.
This may have future industrial applications.
TLC analysis proved to be an adequate screening technique, but when
quantitative methods were required, HPLC with RI was found to be the more
appropriate method for monitoring GOS synthesis.
A simplified reaction mechanism model, that would take into consideration the
enzyme concentration, was proposed and used to fit GOS synthesis experimental data.
The estimated parameters from experiments were successfully used to compare and
interpret changes in the reaction profile. Changes in model parameters due to the use
of different lactose or enzyme concentrations, the use of solvents in the reaction
media or due to the employment of different enzyme sources were investigated.
A maximum GOS yield of 24% was achieved, which is comparable with the
present literature results. Although higher yields of GOS have been reported in the
past, they do not seem to be reproducible by most of the studies on
galactooligosaccharides synthesis from different β-galactosidases sources (Tables 1.51.10). Thus, recent reports in the literature do not claim higher than 25% GOS
production despite the wide variety of enzymes and reaction conditions used. It is
possible that this is due to the fact that this reaction is governed by thermodynamic
factors that are not greatly influenced by reaction conditions.
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Increasing enzyme concentration resulted in faster synthesis and degradation
of GOS for a given WP concentration. Increasing WP concentration increased the
level of GOS synthesised and increased the time taken to reach maximum GOS
concentration.
Using 10% acetone, diethyl ether and ethanol influenced the profile of the
GOS reaction progress, apparently shifting the kinetics towards GOS production and
away from hydrolysis.
Comparison of two β-galactosidases under identical conditions showed that
they had the same GOS synthesis profile when initial rates were normalised. From
this work it is clearly necessary to have a common protocol to compare βgalactosidases from different sources. This would ameliorate the difficulties in
obtaining any meaningful benchmark from previous results in the literature.
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6 Further work proposed
On the basis of the results obtained in this work, it would be interesting to
carry out further research to investigate the effect of higher WP concentration on GOS
maximum yield and to study the effect of viscosity of the reaction medium on the
enzymatic reaction. Particularly, the effect of 0.4 and 0.8% Maxilact on
concentrations of 450 and 550 g/l Whey Permeate should be tested.
Considering the results with solvent addition, work should be carried out to
examine increasing the level of the solvent to 20 and 30%, for example. The solvents
most interesting for further study are acetone and ethanol, as these were shown to
positively influence the kinetic parameters of the GOS synthesis reaction.
Furthermore, it may be interesting to study solvent addition to concentrated Whey
Permeate solutions. This would provide the possibility to combine the favourable
effect of reduced water activity due to the solvent with high substrate concentration,
which might improve GOS final yield.
A standard GOS assay for β-galactosidase should be adopted in order to have
a comparable set of conditions to benchmark different literature studies present on the
subject.
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